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ABSTRACT 
Infection related death is of major concern world-wide. This is especially true in 
developing countries where there is a high burden of disease. In some cases 
infections may present atypically and death occurs without a diagnosis in life. Many 
countries, including South Africa, classify these deaths as sudden unexpected or 
unexplained, which, under the Inquests Acts, necessitates a medico-legal autopsy. 
In order to understand the mechanisms underlying such deaths, a systematic review 
of the literature was undertaken on sudden death due to infection. Data from 
published research and reports identified many pathogens associated with sudden or 
unexplained death in infants and older individuals. However it remains important to 
understand locally relevant pathogens. In addition, many risk factors have been 
identified in different age groups but it is not known what risk factors are prevalent in 
a local setting and if these correspond to international trends.  
In order to contribute to local data a case file review was undertaken of infection 
related deaths at Salt River Mortuary between 1 January 2013 and 31 December 
2014 (n=809). Deaths due to respiratory infections were the leading cause of death 
across all ages and in both sexes. It is not known to what degree this is a true 
reflection of the cause of death as the extent of autopsy, ancillary investigations and 
availability of ante-mortem clinical information varied widely.  There has been a call 
for standardised protocols for the post-mortem investigation of these deaths and the 
data analysed reiterated this need. Many of the modifiable risk factors for infant 
death identified in the literature review were also identified in the Western Cape 
Metropole area, with the exception of sleeping position: side sleeping, as opposed to 
prone sleeping, was identified as the distinctive risk factor. In older individuals 
tuberculosis was identified as either the cause of death or a major contributor to co-
morbid conditions, which highlights the importance of further surveillance of 
vulnerable individuals. These data have provided insight into the extent of infection 
related death and associated risk factors in a local context. A standardised protocol 
for the investigation of these deaths across mortuaries would enable more accurate 
data to be collected which in turn could be fed back into the healthcare system.  
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Chapter 1 
 
A systematic review exploring the relationship between 
infection and sudden unexpected death between 2000 and 
2016: a forensic perspective 
 
Summary 
Death due to infectious diseases is a major health concern worldwide. This is of 
particular concern in developing countries where poor-socio economic status and a 
lack of healthcare resources contribute to the high burden of disease. In some cases 
death due to infection can be acute and aggressive, and death may occur without a 
diagnosis whilst the person is still alive. These deaths may ultimately lead to a 
medico-legal autopsy being performed.  
There are various mechanisms by which sudden death due to infection may occur. In 
addition, there are many risk factors associated with sudden death due to infection, 
which differ between infants and older individuals. However, it is unclear which 
pathogens and risk factors are most frequently associated with sudden death due to 
infection. Therefore a systematic review of articles and case reports published 
between 1 January 2000 and 30 June 2016 was undertaken in order to (1) explore 
the relationship between pathogens and their causative role and (2) identify the 
relationship between predisposing and/or risk factors associated with sudden death 
due to infection. Major databases were searched and after critical appraisal 143 
articles were identified. It was found that respiratory infections and deaths involving 
bacterial pathogens were most commonly associated with these deaths. In addition 
the most common risk factors in infants were exposure to tobacco smoke and co-
sleeping. In adults the most common risk factors were co-morbid conditions and 
illnesses.  This information could be used to compare with South African trends 
which would aid in a better understanding of these deaths.  
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1.1 Introduction 
 
Each year the vast majority of deaths worldwide are attributed to natural causes. 
According to the World Health Organisation (WHO) the top seven leading causes of 
death worldwide are due to a natural disease, process or event, with lower 
respiratory tract infections being fourth on the list [1].  
 
The WHO estimates that death due to communicable diseases is approximately 
611.6 per 100 000 people in South Africa [2]. Some of these deaths occur suddenly 
and unexpectedly or the cause of death is not immediately apparent. Sudden, 
unexpected or unexplained deaths are defined as unnatural deaths in the 
Regulations (No. 636 of 2007) of the National Health Act (Act 61 of 2003) [3].  
Therefore they require a medico-legal autopsy to be performed as per the Inquests 
Act 58 of 1959 [4].  
 
Sudden and unexpected deaths in adults (SUDA) are often due to cardiac related 
events [5]. However many sudden unexpected deaths in infants (SUDI) are due to 
infections, notably in developing countries [6,7]. Sudden unexpected death in infants 
is defined as death of an infant occurring under one year of age [8]. Sudden and 
unexpected death due to infection occurs when the infection presents acutely and 
aggressively, and death occurs without a prior clinical diagnosis [9].  
 
Infant mortality due to natural causes is of concern, particularly in developing 
countries such as South Africa. However in some cases the exact cause of death 
remains unclear [10]. The common bacterial toxin hypothesis for sudden infant death 
syndrome (SIDS) aims to explain the complex interplay between viral infection, 
bacterial toxin accumulation, the immune response and environmental risk factors 
such as prone sleeping and exposure to cigarette smoke [11]. Since this hypothesis 
was first presented, much research has sought to explicate this interplay. More 
recently the body of evidence increased to support that an infectious aetiology could 
be present in many SIDS cases [12].  
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In contrast, not many studies have been conducted on infection related sudden 
death in individuals older that one year, although many single case reports have 
been published. In addition, there are some case reports in the literature that 
disentangle suspected foul play by elucidating an underlying infection as cause of 
death [13–16]. This is an important aspect to consider in the forensic pathology 
setting.  
 
The WHO established Millennium Development Goals (MDGs) in 2000. MDG 
number 4 was to reduce child mortality and number 6 was to combat HIV/AIDS, 
malaria and other diseases (including tuberculosis) [17]. As infection is one of the 
leading causes of child mortality [18], it is important to understand which pathogens 
and risk factors are associated with these deaths, when death occurs suddenly and 
unexpectedly.  
The identification of these pathogens and risk factors in a global context is important 
in order to establish comparative data with which locally sourced information can be 
compared and contrasted. By adopting this approach a more comprehensive body of 
evidence can be presented to the healthcare system which may aid prevention 
campaigns and strategies which include the updating of vaccination schedules and 
creating awareness surrounding modifiable risk factors. To this end, a systematic 
approach was adopted to review the literature on infection related sudden and 
unexpected or unexplained deaths between 2000 and 2016. 
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1.2 Objectives 
 
The first objective was to explore the relationship between pathogens and their 
causative role in the sudden unexpected deaths of (i) infants and (ii) older 
individuals.  
The second objective was to explore the relationship between predisposing and/or 
risk factors associated with sudden death due to infection in (i) infants and (ii) older 
individuals.  
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1.3 Search Strategy 
 
The search strategy applied for this review included searching the databases 
PubMed and Scopus and the meta-database, Web of ScienceTM. “Hand-searching” 
was done by evaluating every reference in the reference list of a journal article. The 
meta-database www.crossref.org was used to find publications referenced in journal 
articles recalled during a database search. Crossref is a reference linking service 
which allows for citations to be linked via their Digital Object Identifiers (DOI). This 
meta-database does not contain full text articles but rather serves to efficiently link 
scholarly literature [19].  
 
A “hand-search” of PubMed and Web of ScienceTM yielded additional articles. A 
“hand-search” of articles selected from Scopus revealed only unsuitable and 
redundant articles. Additionally, five discipline specific journals were chosen to 
ensure that relevant articles were not overlooked during database searching. A 
summary of articles returned (the results that the database or journal displays) and 
retrieved (articles chosen according to inclusion and exclusion criteria), with the 
results of “hand-searching” is represented in Table 1 (section 3.3.5). As a result of 
the systematic approach adopted redundant articles were immediately identified in 
the search and not included in the body of literature used in the analysis of this 
review. Review articles were included in the article count; however they were only 
used as sources to “hand-search” for original research papers and case reports.  
 
1.3.1 Inclusion and exclusion criteria 
The inclusion and exclusion criteria were applied by reading the abstract and/or 
scanning the article. Only English articles adhering to the concepts as set out in 
Table 1.1 were included.  
 
Articles published before the year 2000 were excluded. Limiting the publication years 
in this way ensured that the most up-to-date information was reviewed.  
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The only exception to this was an article by J.A. Morris in 1999, as it is deemed 
seminal work related to the common bacterial toxin hypothesis in SUDI cases [11].  
 
Table 1.1 Inclusion and exclusion criteria applied to articles during the search of the 
literature 
Inclusion criteria Exclusion criteria 
 Infection related to sudden death. 
 The diagnosis of infection at 
autopsy or necroscopy. 
 Trends in sudden death. 
 Complicating factors related to 
infection and sudden death. 
 Inflammation or inflammatory 
responses and sudden death. 
 Sudden unexpected death in an 
infant (SUDI) or sudden infant 
death syndrome (SIDS). 
 Sudden unexpected death in an 
adult (SUDA). 
 Sudden death related to any virus, 
bacteria, fungus or other 
pathogen. 
 Iatrogenic deaths. 
 Animal model studies. 
 Traumatic or procedure related 
deaths. 
 Cardiac related deaths that did not 
have an infectious cause. 
 Sudden deaths attributed to a 
neurological incident that did not 
have an infectious cause. 
 
 
1.3.2 Systematic search of literature 
1.3.2.1 PubMed search terms 
The Medical Subject Headings (MeSH) database was used to create the search in 
PubMed. MeSH was used to index articles in PubMed via a controlled vocabulary 
thesaurus. The following is the search output generated from the MeSH terms:  
((("Infection/microbiology"[Mesh] OR "Infection/immunology"[Mesh]) OR 
"Infection/physiopathology"[Mesh]) OR "Infection/virology"[Mesh]) AND "Death, 
Sudden"[Mesh]. 
1.3.2.2 Web of ScienceTM search terms 
Web of ScienceTM was used to incorporate additional databases in the search for 
appropriate literature. Searching within this website allows for the search to be done 
within the following databases:  
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Web of ScienceTM Core Collection; Biological Abstracts®; KCI-Korean Journal 
Database; MEDLINE®; Russian Science Citation Index; SciELO Citation Index; 
Zoological Record®. The following keywords were used: Sudden death AND acute 
death AND infection.  
1.3.2.3 Journal specific search terms 
Due to the nature of this review searches were conducted within five subject specific 
journals. The keywords used were sudden AND unexpected AND death AND 
infection.  
1.3.2.4 Scopus search terms 
A search within the database Scopus was conducted. For the full text search 
parameters, refer to the supplementary material.  
1.3.2.5 Summary of articles retrieved for the search strategy 
Through the systematic search of the literature and after applying the inclusion and 
exclusion criteria a total of 213 articles were identified as presented in Table 1.3 
(section 1.3.3).  
1.3.3 Quality criteria 
The search strategy outlined above returned 213 articles; including case reports, 
retrospective studies and original research. Case reports generally represent 
exceptions rather than the rule; however, given the rarity and complicated nature of 
sudden deaths due to infection, case reports when collated may represent valuable 
information and data. Certain criteria were applied to these articles to assess the 
quality of the data and information contained therein. Quality criteria (Table 1.2) stem 
from the objectives of this review and allowed for appropriate analysis of the 
available literature. If ‘no’ was answered to any of the core criteria the article was 
excluded which resulted in a total of 143 articles used in the analysis of the literature. 
Additional literature was used to contextualise concepts and arguments.  
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Table 1.2 Quality criteria applied to the 213 identified articles 
Case Reports Retrospective studies and original research 
 Does the information contained 
within the case report fall within the 
scope of this review? (Core criteria) 
 Does the case report contain 
adequate information in order to 
appraise the outcome of the report? 
(Core criteria) 
 Were the same results discussed in 
different journal articles?(Core 
criteria) 
 Did the author(s) cite appropriate 
literature? 
 How recent is the report? 
 Is it a ‘novel’ report, i.e. would this be 
the first time it is reported in the 
literature (according to the author)? 
 
 Does the information relate to either objective 
1 or 2 of this review? (Core criteria) 
 Was the information reported in the study 
outlined in a way that is easy to follow or 
understand? 
 Did the authors report any novel findings? 
 Did the authors corroborate or ‘disprove’ 
previous findings or reports? 
 How recently was the study conducted? 
 Over how many years was the review 
conducted? 
 Did the authors use appropriate statistical 
tests to validate their findings? 
 What are the strengths and limitations of the 
study? 
 Were the same results discussed in different 
journal articles? (Core criteria) 
 
Through the systematic search of the literature and applying inclusion and exclusion 
criteria a total of 213 articles were returned of which 143 were used in the analysis of 
the literature following assessment according to the quality criteria. In this review the 
most common pathogens were determined based on the actual number of medico-
legal cases and not the number of articles associated with the pathogen.  
Table 1.3 Summary of the articles returned during the search strategy and total 
number used in the analysis of the literature 
Source 
Date 
accessed 
Articles 
returned 
Articles retrieved 
(section 3.1 and 3.2) 
Articles found via 
“hand-searching” 
Total number 
of articles 
PubMed 01/04/2016 96 25 81 106 
Web of 
ScienceTM 
12/04/2016 276 29 48 77 
Forensic 
Science 
International 
21/04/2016 
117 9 0 9 
Journal of 
Forensic 
Sciences 
21/04/2016 
64 8 0 8 
International 
Journal of 
Legal 
Medicine 
21/04/2016 
41 5 0 5 
Legal 
Medicine 
21/04/2016 42 4 0 4 
Journal of 
Forensic and 
Legal 
Medicine 
21/04/2016 
43 10 0 10 
Scopus 23/04/2016 166 12 0 12 
    Total 231 
Total number of articles used in literature analysis following the application of the quality criteria = 143 
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1.4 Interpretation and analysis of the literature 
1.4.1 The relationship between infection and sudden unexpected death 
with particular attention to the identification and/or causative role of the 
pathogen 
A systematic appraisal of the literature on SUDI and sudden death in older 
individuals was conducted to identify cases and research studies where infection and 
causative pathogens were reported. Articles on SUDI amounted to nineteen 
research studies and ten case reports. A summary of the case reports can be found 
in Appendix A, Table A.1.1. A total of eight research articles and 51 case reports 
were analysed to identify pathogens and associated infections in the sudden death 
of a person older than one year. The literature on this topic tended to be in the form 
of single case reports, which was in contrast to the literature on SUDI.  
1.4.1.1 Pathogens associated with the cause of death in SUDI  
The most commonly reported pathogens in research papers associated with SUDI 
are Staphylococcus aureus [20–24] and cytomegalovirus (CMV) [25–29] followed by 
the fungal pathogen Pneumocystis jirovecii,  formerly known as Pneumocystis carinii 
[30–32] (Fig. 1.1).  
 
 
 
 
 
 
 
 
 
 Figure 1.1 Graphical representation of the pathogens (n=852) associated with sudden 
death in infancy. [20–22,24–32,158,200,202–206] 
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Bacteria 
A retrospective case review at a specialist centre over a ten year period was 
excluded from the quantitative analysis in this review due to nature in which the 
results were reported. However the authors’ findings contribute significantly toward 
understanding infection related SUDI and are therefore discussed here: Cultures 
(n=1628) from infant deaths due to infection showed significantly more growth of S. 
aureus (p=005) and Escherichia coli (p=003) than cultures from infants that died 
from a non-infective cause [8].   
 
SUDI death attributed to sepsis where there was no obvious focus of infection was 
also researched in the article mentioned above [8]. The most significant organisms 
associated with sepsis in SUDI were; S. aureus, E. coli, Streptococcus pyogenes, 
Streptococcus agalactiae, Streptococcus pneumoniae and Neisseria meningitidis. 
There was a significant difference (p<0.0001) between cultures from sepsis related 
SUDI (N=322) and cultures from infants with a non-infective cause of death (n=243) 
[8].  
 
The role of S. pneumoniae in sepsis associated SUDI was highlighted in a case 
where a ten week old infant displayed bone and soft tissue injuries (eventually 
declared accidental). Following a full autopsy with extensive microbiological testing it 
was found that a retropharyngeal abscess had formed which led to eventual 
septicaemia and death [33]. Another case report of a nine month old infant 
highlighted the role of a full autopsy when the death appeared suspicious. 
Microbiological analysis of the cerebrospinal fluid, blood and lung swabs grew pure 
Clostridium perfringens cultures and the death was deemed natural [34].  
 
Neonatal sepsis and meningitis due to Group B Streptococcal (GBS) infections is a 
major health concern in South Africa [6]. In the forensic post-mortem setting it is 
often difficult in obtaining ante-mortem information from parents and caretakers of 
SUDI cases, not just in South Africa but globally. In Japan a GBS infection is 
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routinely screened for in pregnant women before giving birth. An atypical case of 
late-onset disease (LOD) GBS infection was presented when a pregnant woman was 
not screened for a GBS infection and, although the infants’ Apgar score was 10, the 
infant died four days after birth. Pathologists suspected vertical transmission from 
mother to child [35]. Recently it has been suggested that South Africa screen for a 
GBS infection in all pregnant women and administer intravenous antibiotics a 
minimum of four hours before birth [7]. The limitation in most low to middle income 
countries is the high cost associated with antibiotic therapy. However a recent 
vaccine which can potentially prevent up to 80% of invasive GBS infections has 
passed the phase-II evaluation in clinical trials. This vaccine could present a more 
cost-effective strategy to combat neonatal sepsis and meningitis in South Africa [7].  
 
Conflicting results exist with regards to the pathogenic role of Heliobacter pylori as a 
causative pathogen in the sudden death of infants. In 2000, Kerr et al. reported a 
highly significant association between H. pylori and cases of SIDS [36]. However 
much concern was raised regarding this association by others in the field at the time. 
Concerns ranged from researchers critiquing the (then) new technology of PCR to 
possible post-mortem sample contamination  [37]. In 2005 another research group 
concluded that there was no association between the detection of H. pylori and 
sudden death in infants [38]. The research on this pathogen did not move forward 
until 2008 when Stray-Pederson et al. concluded that the detection of H. pylori 
antigen in the stool of SIDS cases may explain the cause of death as this pathogen 
may be the initial event that triggers sudden death in infants, specifically those less 
than five months of age [39]. There are thus many caveats present with regards to 
the understanding of the role that this pathogen plays in the sudden death of infants.  
 
Viruses 
Viral infections has been recognised as an important co-factor which may trigger the 
events leading to SUDI but may be rare as the direct causal infection [40]. However 
certain enteroviral and CMV infections may cause acute myocarditis in infants 
leading to sudden death [41–44]. With application of molecular techniques on heart 
tissue the Coxsackie B3 virus (N=4) and a CMV (N=3) infection was identified in 
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unexplained infant deaths which indicated acute myocarditis. These may otherwise 
have been diagnosed as SIDS which highlights the importance of continual 
application of new techniques in SUDI investigations [42,43]. This was also 
demonstrated in a local context where a research at a large medico-legal mortuary 
indicated the great disparity between standard shell vial cultures and molecular 
techniques in detecting viral pathogens such as CMV, RSV and adenoviruses [28].  
Other viral infections associated with SUDI include the influenza virus A, Epstein-
Barr virus and human herpes simplex virus 6 [44]. A recent report indicated that the 
relatively benign Coxsackie Virus A16 may also be a contributing factor in SUDI [45].  
 
Chicken pox is caused by the varicella zoster virus and usually affects young 
children as opposed to infants. The German Standing Committee recommends 
vaccination against chicken pox for all children over the age of eleven months [46] 
however vaccination for varicella zoster is not part of the required immunisation 
schedule in South Africa [47]. A report in 2013 found that the co-infection of CMV 
and varicella zoster lead to the sudden death of a two month old infant [48]. A 
vaccine against CMV has been a top priority for the past four decades but until 
recently, the development of a safe and protective vaccine has been limited. Phase-
II clinical trials for a CMV vaccine showed promising results in 2014 which 
encouraged further research [49]. Factors such as these contribute to the 
development of immunisation schedules around the world, which is a critical part of 
the healthcare system.  
 
Cardioviruses are viruses that occur in rodents and lead to myocarditis and 
encephalomyelitits. Human cardioviruses (hCV) have been detected in clinical 
samples from children who suffered from diarrhoea and respiratory infections [50]. In 
2011 hCV was detected in the CSF of an infant where the cause of death was 
initially classified as SIDS. This is the first reported case where hCV was detected in 
a body compartment (i.e. the central nervous system) other than the respiratory or 
gastro-intestinal organ systems [51].  
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Fungi 
A molecular typing technique was developed in 2004 for the typing of Pneumocystis 
species in formalin fixed paraffin embedded tissue. A case series involving three 
infants under the age of three months whose cause of death was initially SIDS was 
investigated. After applying the molecular typing technique the researchers identified 
Pneumocystis jirovecii in the lung tissue of the infants, thus altering the cause of 
death from SIDS to P. jirovecii pneumonia [31]. Their findings supported the 
hypothesis set forth by Morgan et al. in 2001 that humans can act as a reservoir for 
this fungus and that it plays a causative role in respiratory infections leading to 
sudden death in infants [30]. 
1.4.1.2 Pathogens associated with the cause of death in sudden unexpected deaths 
in children and adults  
Case report analysis of the literature in this review found Mycobacterium 
tuberculosis, E. coli, S. pyogenes and S. agalactiae were the most commonly 
reported bacterial pathogens associated with sudden infectious deaths [13–15,52–
57] (Fig. 1.2). The tapeworm Echinococcus granulosus was also reported a number 
of times where the affected individual died as a result of a ruptured hydatid cyst 
leading to septicaemia and toxic shock [58–61]. 
 
 
 
 
 
 
 
 
 
 Figure 1.2 Case report analysis of the pathogenic bacteria, fungi and parasites reported to be 
associated with sudden infectious death [13–16,52–61,81,83,87,88,90–93,95,97–105] 
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Bacteria 
Septicaemia is a life-threating response to infection when the infection damages the 
tissue and organs of the individual. The course of these infections can be lethal 
causing death as a result of sepsis [62]. However, as mentioned before, ante-
mortem clinical information may be difficult to obtain in the forensic setting and may 
be the reason behind the medico-legal autopsy of an individual. Sudden or 
unexplained death due to sepsis have been associated with the following bacteria; 
Acinetobacter baumanii, E. coli, Enterococcus species, Pseudomonas aeruginosa, 
Klebsiella pneumonia, Proteus mirabilis, S. aureus, Enterobacteria species, S. 
pneumoniae and the yeast like fungus Candida albicans [63]. Although post-mortem 
microbiology can be difficult to interpret [64] it is beneficial with regards to 
determining the point of origin in suspected sepsis cases, providing insight into 
emergent species and can aid in profiling drug resistance [63].  
 
A fulminant bacterial infection which leads to sudden death might indicate a chronic 
underlying disease [65]. A mechanism of action was proposed whereby bacteria 
which enter the bloodstream and are resistant to phagocytosis will invade the blood 
via the intestinal tract, after which the pathogens migrate to the liver through the 
portal vein. Once the bacteria are in the liver proliferation and migration to the 
bloodstream occurs, leading to bacteraemia and sudden death, especially in 
individuals with chronic underlying conditions such as liver cirrhosis and splenic 
dysfunction [66]. 
 
Viruses 
The most commonly reported viruses from case reports were Parvovirus B19, 
Adenovirus, Epstein-Barr virus and Influenza A virus [44,67–77] (Fig.1.3).  
A parvovirus B-19 infection may cause acute fatal myocarditis [26,67,69], especially 
in the young, although it has been detected in individuals who died of non-invective 
causes. Thus a parvovirus B-19 infection may present as a long-term infection and it 
is uncertain to what degree it contributes to the inflammation of the myocardium [78]. 
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A CMV infection  [26] and infection from the Coxsackie virus B3 [9,79] have also 
been associated with acute fatal myocarditis. 
 
 
 
 
 
 
 
 
 
 
 
Parasites 
Hydatid disease, also known as human echinococcosis is a zoonotic infection 
caused by the tapeworm, Echinococcus granulosus. In most cases these cysts are 
found in the liver and occur mostly in young adults. A traumatic event may cause the 
cyst to rupture and death is due to anaphylactic shock. If the traumatic event 
precipitates a medico-legal autopsy and a ruptured cyst is found it may aid to 
distinguish whether the manner of death was homicidal or accidental [80].  
 
Discussion 
Case report analysis of infection related sudden death in children and adults non-
infants revealed that the highest number of case reports originated from Germany 
(21%) and America (14%), followed by Australia, India and Japan (9% each) 
(Appendix A, Fig. A.11). Resources, as allocated through legislation, in developed 
countries lend themselves towards aiding the investigation of sudden unexpected 
deaths and as a result many case reports are published. The lack of resources in 
many developing countries may hinder these investigations and thus the publication 
Figure 1.3 Pathogenic viruses reported to be associated with sudden infectious death in 
individuals older than one year [16,44,67,69–77,84,89,94,96,106,222,223] 
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of case reports. Locally there are medico-legal mortuaries that are classified as M6 
academic facilities which allow research to be conducted and published on topics 
such as sudden death and case reports. One such case report revealed the sudden 
death of an apparently healthy adult male was due to myocardial TB [81]. Adding to 
local research would better our understanding of the temporal differences in infection 
related sudden death.  
 
Respiratory infections were the leading cause of death and had the highest number 
of associated pathogens from the collated case reports between 2000 and 2016. 
Sepsis and myocarditis were also highly cited as causes of sudden death with 
multiple associated pathogens (Table 1.4).  
 
Respiratory infections include deaths due to pulmonary tuberculosis (TB) although 
M. tuberculosis may disseminate in the body and be associated with infections such 
as pericarditis and [54]. The WHO estimates that the incidence of active TB in South 
Africa was 450,000 cases in 2013. Of the 52 districts in South Africa there are only 
ten in which TB is not the leading cause of death [82]. However there is a lack of 
uniform information regarding the prevalence of TB in the South African medico-legal 
mortuary setting. 
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Table 1.4 A summary of the organ system, type of infection and associated pathogen compiled 
from case reports [13–16,18,52–61,67,69–77,81,83–106] 
 
 
Organ System 
affected 
Type of infection Associated Pathogens 
Multi-organ 
involvement 
Acute rheumatic fever group A streptococcus 
Bilateral tonsillar enlargement & narrowing of upper 
airway 
Epstein-Barr virus 
Necrotizing fasciitis group A streptococcus 
Septicaemia 
 
Clostridium fallax 
Clostridium perfringens 
Escherichia coli 
Staphylococcus aureus 
Toxic Shock Syndrome group A streptococcus 
Streptococcus suis  
Cardiovascular 
system 
Acute coronary thrombosis Coxsackie virus B2 
Endocarditis 
Gram-positive cocci 
Staphylococcus aureus 
Streptococcus mitis 
Infectious aortitis Clostridium septicum 
Myocarditis 
Campylobacter jejuni 
Epstein-Barr virus 
Influenza A (H3N2) virus 
Parvovirus B19 
Pericarditis Mycobacterium tuberculosis 
Cardiac hydatid cyst Echinococcus granulosus 
Syphilitic aortitis Treponema pallidum 
Viral myocarditis Adenovirus serotype 3 
Nervous 
system 
Cerebral malaria Plasmodium falciparum 
Encephalopathy Rotavirus 
Influenza encephalopathy Influenza A virus 
Meningitis Streptococcus pneumoniae 
Meningococcemia Neisseria meningitides 
Meningoencephalitis group B streptococcus 
Viral meningitis Adenovirus 
Influenza A virus 
Respiratory 
System 
Laryngotracheitis Human parainfluenza virus–1 
Pneumonia group B streptococcus 
Respiratory infection 
Adenovirus 
Aspergillus species 
Influenza A/H1N1 
Mycobacterium tuberculosis 
Parainfluenza virus type 2 
(PIV2) 
Respiratory syncytial virus 
Streptococcus pneumoniae 
Varicella zoster 
GIT System 
Gastrointestinal Infection Bacillus cereus 
Clostridium difficile 
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1.4.2 The risk or predisposing factors that are related to sudden 
unexpected death due to infection.  
There are vast amounts of literature available for risk factors associated with sudden 
infant death. In this review, research conducted on SUDI, with particular attention to 
an infectious aetiology (24 articles), was appraised. In addition, the risk factors for 
non-infants were compiled through assessment of case reports and case series 
descriptive studies (31 articles).  
1.4.2.1 Risk factors associated with sudden infant death due to infection 
The broad categories for risk factors were: developmental, maternal, environmental, 
genetic, health-status related, illness and other/modifiable factors such as prone 
sleeping position (Table 1.5).  
Table 1.5 Risk factors associated with infection as a cause of sudden infant death 
Type of Risk Factor Specific Risk Factor Reference(s) 
Developmental 2-4 months of age [83] 
Maternal Risk Factors 
Alcohol use during pregnancy [84] 
Illicit drug use during pregnancy [84] 
Pre-natal smoking [84–86] 
Environmental 
Air pollution [83,87] 
Co-sleeping [84,85,87,88] 
Contaminated food [89] 
Overheating [83] 
Quality of mattress [83,84,87,90] 
Second hand smoke exposure [83,84,91–94] 
Poor socio-economic conditions [83,84] 
Genetic 
Ethnicity [83] 
Male sex [83,95,96] 
IL-6 polymorphisms [83,97,98] 
IL-10 polymorphisms [83,99–101] 
IL-1β polymorphisms [83,102] 
TNF-α polymorphisms [103] 
Health status related 
No or late vaccinations [83,104] 
Lack of maternal vaccination against GBS [7] 
Illness Mild respiratory infections [83,84,93] 
Other/ 
modifiable 
Physical Injury [33] 
Lack of breast-feeding [83] 
Mode of delivery [87] 
Prone sleeping position [83,84,88,93] 
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The most common risk factor for SUDI identified in this review (6 research articles) 
was exposure to second hand smoke [83,84,91–94]. Second hand smoke inhalation 
implies that there is less exposure to the harmful constituents of smoke; however, 
some research indicated that there were detectable levels of nicotine (in hair) and 
cotinine (in pericardial fluid and CSF) in infants who succumbed to sudden death 
[105–108]. Recent local research has also shown that detectable levels of cotinine 
can be found in infant urine, indicating the need for urgent intervention in local 
communities [109]. Cotinine is a metabolite of nicotine and has shown to increase 
the production of pro-inflammatory mediators. In an experimental model it was 
shown that buccal epithelial cells treated with cigarette smoke increased the binding 
of staphylococci bacteria [110]. A comparison can thus be drawn between second 
hand smoke inhalation as a risk factor and the prevalence of S. aureus as the 
causative pathogen in many infection related sudden death cases of infants. In 
addition, recent research has indicated that when exposure to second hand smoke is 
combined with co-sleeping, the risk of sudden death in an infant increased 
significantly [85].  
 
The common bacterial toxin hypothesis for SIDS includes risk factors such as prone 
sleeping and exposure to second hand smoke [11]. Many studies have aimed to 
elucidate the mechanism of death in SIDS cases and there is a recent trend towards 
exploring an infectious aetiology for these deaths [84]. There are well recognised risk 
factors for SIDS and these parallel those for infection.  
 
The toxins produced by bacteria such as S. aureus and E. coli are absorbed in 
mucosal membranes. This creates "channels" in the membranes which disrupt the 
transport of smooth ions. This in turn affects the function of the cardiovascular and 
respiratory systems [84]. Due to the immature immune system of an infant a mild 
viral infection can be a risk factor for colonisation and toxin production by bacteria 
which can lead to sudden death [28,40]. These observations add to the body of 
evidence for the common bacterial toxin hypothesis as a possible mechanism in 
some SIDS cases.  
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Prone sleeping position and co-sleeping were the second most common risk factor 
[83–85,87,88,93]. The underlying reason for prone sleeping as a risk factor was 
described as the pooling of secretions into the upper airways of the infant in this 
position. This caused an increased risk of bacterial growth and thus bacterial toxin 
production [11,111].   
 
Polymorphisms in genes IL-1β (NG_008851.1), IL-10 (NG_012088.1), IL-6 
(NG_011640.1) and TNF-α (NG_007462.1) have been associated with an increased 
risk for sudden infant death [83,97–103]. Disturbances in inflammatory responses 
contribute significantly to tissue damage as a result of the response to infections 
[112]. Powerful pro-inflammatory responses and suppression of anti-inflammatory 
responses such as IL-10 lead to sudden death in infants with infections. These 
responses are dictated by the genetic make-up of the infant but are mediated or 
exacerbated by environmental factors such as cigarette smoke [83].  
 
Primary immunodeficiency disorders (PID) are a rare group of inherited immune 
system defects [113]. PID predisposes an individual to a wide range of infections 
which may present atypically and is dependent on the underlying variation. There 
exist almost 250 different PIDs grouped into nine categories to which new sub-types 
are continually being added [114]. These disorders are diagnosed in infants and 
young children [113] and could be one mechanism underlying the infectious cause of 
sudden unexpected deaths in infants.  
 
A higher proportion of male SUDI deaths have been described in the literature. 
However the exact reason for this difference is not well understood. One hypothesis 
is that an increase in testosterone levels in male infants might affect the 
dysregulation of inflammatory responses to ‘mild’ infections [95]. In turn these ‘mild’ 
infections are an additional risk factor for sudden infant death under the common 
bacterial toxin hypothesis [11,84].  
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1.4.2.2 Risk factors for sudden death in children and adults 
Health status related risk factors was the category most commonly associated with 
an increased risk for sudden death due to infection (Table 1.6). The possible 
biological mechanism is intuitive as many of the conditions and diseases lead to a 
compromised immune system, leaving the individual vulnerable to infection.  
 
Illicit drug use, particularly methamphetamine abuse, was the most commonly 
associated specific risk factor [115–117]. Opiates, marijuana and cocaine all modify 
the immune system and immune response to infection in a variety of ways leading to 
increased susceptibility and severity of infection. Alcohol, a commonly abused 
substance, inhibits the production of cytokines such as TNF-α, which play an 
important role in antimicrobial immunity [118].  
 
Illicit drug injection was a major risk factor for infective endocarditis (IE). There was a 
variety of mechanisms by which intravenous drug abuse can cause IE. Some of 
these include; (1) particulates in the drugs that damage cardiac valves (2) poor 
hygiene associated with illicit drug injection (3) injecting contaminated drug solutions 
with a high microbial load [119]. In one case study the mechanism of death was a 
fatal pulmonary embolism caused by the detachment of a large vegetation at the 
tricuspid valve. This vegetation was as a result of IE precipitated by long-term 
injection of illicit drugs [120].  
 
Male gender was also a reported risk factor for non-infants. It was proposed that 
there may be an underlying genetic cause for the male excess seen in these deaths 
[96] since the X chromosome contains the largest amount of immune system related 
genes in the genome [121]. Therefore the loss of heterozygosity in the male genome 
could explain the increased susceptibility of males to infection throughout their 
lifetime [96].  
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Table 1.6 Risk factors associated with sudden death due to infection in individuals older than 
one year 
Type of Risk Factor Specific Risk Factor Reference(s) 
Drugs of abuse 
Alcohol [53,118] 
Illicit drug injection [119] 
Illicit drug use [16,118,120,122,123] 
Methamphetamine abuse [115–117] 
Nicotine [118] 
Environmental Contaminated food [59,124,125] 
Genetic 
Male sex [96,126] 
IL-1β polymorphisms [127] 
Health status related 
 
Atherosclerosis [128,129] 
Body mass index [53,126] 
Cholesterol (HDL & Total) [126] 
HIV status [116] 
Hypertension [126] 
Lack of immunisation [130,131] 
Active smoking [126] 
Diabetes mellitus [53,126] 
Kidney disease [16] 
Liver cirrhosis [132] 
Tuberculosis [133] 
Varicella [15,134] 
Pre-existing conditions 
Congenital ventricular septal defect [16] 
Hematologic disorder [132] 
Reye's syndrome [74] 
Sjögren syndrome [135] 
Therapy/Treatment/Medication 
Delayed anti-biotic treatment [136] 
Long term steroid therapy [135] 
Methadone [9] 
Other 
Exercise [54,137,138] 
Age [126] 
Burns/wounds [134] 
 
Many of the risk factors associated with sudden death are related to the optimal 
functioning of the individual’s immune system. However some risk factors leading to 
a compromised immune system are modifiable (e.g. drug use, exposure to cigarette 
smoke, lack of immunisation). Additional research into the prevalence of locally 
relevant risk factors would help to identify vulnerable communities.  
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1.5 Conclusion 
Many pathogens have been associated with an increased risk for SUDI. However 
regional data reflects the environmental, social and epidemiological factors and it is 
important to understand not only globally recognised pathogens but also locally 
relevant infections triggering SUDI. This is especially critical in low and middle 
income countries where the burden of disease is higher than in the developed world.  
 
Globally, well-recognised risk factors for SUDI, including second hand smoke 
exposure and sleeping position, have been studied extensively over the course of 
many years. However, the prevalence of modifiable risk factors known to decrease 
the likelihood of SUDI has not been extensively investigated in developing countries 
such as South Africa. There may also be risk factors unique to local communities 
which need to be assessed.  
 
Pathogens identified to cause sudden death in children and adults are often 
associated with nosocomial infections affecting immunocompromised individuals. In 
addition, M. tuberculosis was highly reported in the literature which indicates the 
particular attention paid to this pathogen not just in South Africa but abroad. As 
South Africa has a high incidence of TB it is relevant to understand the prevalence of 
TB in the context of local forensic autopsies. Thus the health status of an individual 
plays a crucial role in their susceptibility to infection and consequential sudden 
death. Monitoring community specific risk factors would be beneficial in 
understanding locally relevant infections seen at medico-legal mortuaries.   
 
The information compiled in this review allows for an understanding of the role of 
infection as a cause of sudden and unexpected death. There are certain pathogens 
that are globally recognised to be more prevalent in different age groups which may 
direct assessment of local data. It would be beneficial to add to the existing 
information from local medico-legal mortuaries in South Africa in order to better the 
understanding of locally relevant pathogens and risk factors.  
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Chapter 2 
 
Investigating the Prevalence of Infection Related Death at 
Salt River Mortuary for the years 2013-2014 
Summary 
In many developing countries there is a high burden of communicable diseases and 
risk factors for infections are widespread due to poor socio-economic status and a 
lack of resources within the healthcare system. Some infections present atypically 
and death may occur without diagnosis whilst the person is alive. In these cases a 
medico-legal autopsy may be performed in order to establish the cause of death. 
Since a standardised protocol is not yet available in South Africa, it is unknown what 
variations in autopsy approach exist, in how many cases microbiological tests are 
conducted and what are the associated pathogens. Furthermore the risk factors for 
these deaths have not been critically analysed in a local context. In addition, analysis 
of the demographics of these individuals would aid in identifying at-risk groups. In 
order to address these gaps a retrospective review of case of files was undertaken at 
Salt River Mortuary which services the Western Cape Metropole area. In total there 
were 809 cases identified in this study, with almost half (n=392) consisting of infants. 
Respiratory infections were the most common cause of death at all ages. However, 
ancillary investigations were only conducted in 18,5% (n=150) of cases and in only 
54.7% (n=82) of those was a pathogen identified. In infants, co-sleeping and the side 
sleeping position were significantly associated (p<0.0001). In addition, the month of 
death and sex of the infant were significantly associated (p=0.013) with more than 
twice the percentage of male (10.97%) compared to female (4.85%) deaths in June. 
In children and adults the most common co-morbid condition was tuberculosis and 
most of the identified pathogens were opportunistic, usually affecting 
immunocompromised individuals.  
A standardised protocol would aid to better direct autopsy investigations and 
resources in the local setting. In addition this would allow for information to be 
uniformly shared in South Africa and could be used in the healthcare system to 
promote awareness and identify vulnerable individuals. 
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2.1 Introduction 
2.1.1 Background 
In the year 2012 the World Health Organisation (WHO) estimated that deaths due to 
communicable diseases in South Africa were 611.6 per 100 000 people [2]. In 
addition, the leading cause of mortality in Africa for children under five was infectious 
diseases [139]. Most of these deaths occur after diagnosis, either from intervention 
occurring too late or as a result of a drug resistant pathogen or various other factors 
(ref). However, there are some cases in which infections are not diagnosed before 
death and the cause of death remains unexplained until the deceased undergoes a 
medico-legal autopsy.  
In South African law, the Inquests Act (Act 58 of 1959), mandates that all unnatural 
deaths undergo a medico-legal autopsy [4]. An unnatural death, as defined in the 
Regulations (No. 636 of 2007) of the National Health Act (Act 61 of 2003), can be as 
a result of force (physical, chemical or other), an act of commission or omission, as a 
result of a medical procedure or a death that is unexpected or unexplained [3].  
In some cases the course of an infection can present atypically, acutely and/or 
aggressively and death subsequently occurs without a diagnosis whilst the individual 
is alive [9] making them sudden, unexpected and unexplained. The World Health 
Organisation (WHO) defines sudden unexpected death as death within 24 hours 
from the onset of symptoms [140]. In South Africa, these deaths are referred to a 
Forensic Pathology Service (FPS) mortuary where an autopsy is performed in order 
to establish the cause of death. These deaths often occur in infants and the young 
and it is important to understand the underlying cause of death [10] as this has social 
consequences as well as implications within healthcare systems [9]. At the M6 
Academic Salt River Mortuary, at least 3000 cases are admitted per annum. Of 
these, nearly one third are admitted as sudden and unexpected/unexplained. 
Furthermore, many of these have an apparent underlying infectious cause.  
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2.1.2 Rationale 
Although sudden and unexpected or unexplained deaths can occur at any age, these 
deaths are unevenly distributed across ages from infants to adults. Children under 
the age of five remain the most vulnerable and these deaths often have an 
underlying infectious aetiology [8,141–145]. Typically, in older individuals sudden 
deaths are associated with cardiovascular causes and this has been studied 
extensively [146–148]. In addition, sudden cardiac deaths in young adults have been 
studied [149], with special attention on athletes [150]. However, there is a lack of 
information on the role of infection in [151] sudden or unexplained deaths in young 
adults and older individuals [152].  
 
It has been regularly reported that the majority of deaths that occur suddenly as a 
result of infection have an underlying respiratory cause [141,153–155]. This has 
been shown to be particularly true in sudden infant deaths [40,91,156,157].  
 
A diagnosis of infection as a cause of death ideally relies on the successful isolation 
and identification of a pathogen from a post-mortem sample, coinciding with other 
post-mortem findings and/or clinical history [64]. This type of investigation thus 
requires a full autopsy to be performed, within the scope of an appropriate 
standardised protocol [28,158,159], such as that proposed by Dempers et al. (2016) 
[160].  
 
There is a lack of standardised protocols in the investigation of sudden or 
unexplained deaths in South Africa [28,148,159], with mortuaries often functioning 
according to internal standard practises[160]. This leads to a lack of uniform data 
across the country which would be useful for feedback into the healthcare system 
[157]. There has been a call for the standardisation of protocols for the investigation 
of sudden infant deaths in South Africa [28,159]. Recently one such protocol was 
implemented in a feasibility study at Tygerberg mortuary in Cape Town. This protocol 
was shown to be effective and could be used as a guide for other mortuaries in 
South Africa [160].  
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An extension of such a protocol for children and adult sudden deaths would be 
beneficial as some of these deaths might be attributed to an incidental infection 
whilst overlooking various other causes [161].  
Therefore, the aim of this study was to identify the types of infections at Salt River 
Mortuary (Cape Town, South Africa) that contribute to the sudden unexpected death 
of an individual with the following specific objectives: (i) analysis of variables 
surrounding the circumstances of death; (ii) evaluation of identified risk factors in 
each age group; and (iii) assessment regarding the outcome and extent of the post-
mortem investigation.  
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2.2 Materials and Methods 
2.2.1 Study design 
A retrospective study design was adopted for the time period 1 January 2013 to 31 
December 2014. The two years were chosen to review case files as these cases 
would have been resolved by the time the study commenced. The study was 
conducted using the Office Autopsy Database (OAD) and case files from Salt River 
Mortuary (Cape Town, South Africa).  
This study received approval by the University of Cape Town, Human Research 
Ethics Committee (HREC REF: 102/2016).  
2.2.2 Data collection 
Relevant cases were identified by filtering the OAD (HREC REF: R036/2014) for all 
cases linked to an infectious cause. . The generated dataset was used to identify the 
relevant hard-copy case files from which further information, not contained in the 
OAD, was extracted. Individuals of all ages and both sexes were included in the 
study.  
All autopsies conducted at Salt River Mortuary contain a “Contemporaneous Note 
(Lab. 27): Salt River Forensic Pathology Laboratory” form, where basic information 
surrounding the death is recorded. The case file also contains an ‘Affidavit in terms 
of Section 212(4), Act 51 of 1977’, which serves as the report generated by the 
forensic pathologist on the major findings during post-mortem examination. In cases 
of sudden unexpected death in an adult, an FPS006(a) form is completed to record 
additional information on the clinical and social history of the deceased. In cases of 
sudden or unexplained death in an infant, an FPS006(b) form is completed to record 
additional medical, social and maternal information. Due to the nature of a 
retrospective case file study, one limitation was that some documentation or 
information was missing from the case file. This contributed to some variables being 
unknown for certain cases. In cases of deceased infants, information regarding 
vaccination status and exposure to human immunodeficiency virus (HIV) was 
obtained from the “Road to Health Card”, if attached to the case file. 
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2.2.3 Data management and statistical analysis 
Data was recorded in a Microsoft Excel® spreadsheet which was kept on the 
premises of the Department of Pathology, University of Cape Town, Faculty of 
Health Science Campus. Data validation steps were performed within the created 
database to remove the possibility of erroneous data. An independent researcher 
randomly selected 30 case files from each year to verify data accuracy, 
completeness and consistency.  
Age was used to classify cases into the following six groups:  
Group A: Less than one year; Group B: 1 to 5 years; Group C: 6 to 17 years; Group 
D: 18 to 40 years; Group E: 41 to 60 years ; Group F: 61 years and older.  
The main variables collected were: age, sex, month of death, cause of death, extent 
of autopsy and outcome of ancillary investigations. In addition, age specific variables 
were recorded. For a description of variables see Appendix B, section B1.1.  
Statistical programs: STATA version 14 (StataCorp., 2015. Stata Statistical Software: 
Release 14. College Station, TX: StataCorp LP) and Microsoft Excel® (Microsoft 
Office Professional 2010, version 14.0.7172.5000) were used for statistical analyses. 
Numerical variables were tested for normality using the Shapiro-Wilk test. 
Hypothesis testing for categorical variables was done using the χ2 test. A p-value of 
less than 0.05 was considered to be statistically significant. Data visualisation was 
done using STATA version 14 and GraphPad Prism version 7.00 for Windows 
(GraphPad Software, La Jolla California USA, www.graphpad.com).  
2.3. Results 
2.3.1 General description of the cohort 
At Salt River Mortuary, from 1 January 2013 to 31 December 2014 there were a total 
of 2312 deaths that were initially classified as sudden and unexpected. Of these, 809 
(35%) deaths were attributed to infection following a post-mortem investigation.  The 
prevalence of sudden unexpected death due to infection was therefore estimated to 
be 6.54 per 100 000 in the Western Cape Province. Group A (infants) represented 
the highest number of deaths in the case series (48.5%, n=392).  
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Group A and B:  
The majority (n=211, 53.8%) of infant (Group A) deaths occurred below the age of 
three months (Fig. 2.1).  
 
 
 
 
 
In group B (one to five years) the highest number of cases occurred between the age 
of one and two (n=24, 64.87%) (Fig. 2.2) 
 
 
 
 
 
Groups A to F: There was a male preponderance in the majority of age groups with 
the exception of Group B (ages between one and five) which had 45.95% (n=17)  
males (Fig. 2.3). In total there were 501 male deaths (61.93%) and 308 female 
deaths (38.07%).  
Figure 2.4 Group A: Percentage (%) of infant deaths by age range. The majority of infant deaths under 3 
months of age were n=211 (53.8%), there was a plateau seen between 7 and 11 months of age with 
between 10 (2.6%) and 11 (2.8%) cases per age range. Between 11 and 12 months there was an 
increase in deaths with 21 (5.6%) cases. 
Figure 2.5 Group B: Number of cases as per age for children between one and five. The majority 
of cases occurred below the age of 2 years (n=24, 64.87%). At 3 years of age there were 8 
(21.62%) cases, at 4 years there were 3 (8.1%) cases and at 5 years there were 2 cases (5.4%).  
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Group C to F: Age was normally distributed for five and above with a median of 46 
(𝑥 = 46.42, 𝑠𝑑 = 17.47,min(6);max⁡(94)). Females had a median age of 47 (𝑥 =
49.1, 𝑠𝑑 = 19.59,min(8) ;max⁡(94) and males had a median age of 46 (𝑥 =
45.36, 𝑠𝑑 = 16.48,min(6) ;max⁡(92) (Fig. 2.4).  
 
 
 
 
 
2.3.2 Cause of death and extent of autopsy 
Respiratory infections were the leading cause of death in 2013 and 2014 (Tables 2.1 
and 2.2). Respiratory infections were defined as: pneumonia, bronchopneumonia, 
lower respiratory tract infections (LRTI), pulmonary tuberculosis and bronchiolitis.  
 
Figure 2.6 Percentage (%) of males and females for all ages (Group A to F). Male deaths accounted for the 
following number of cases; Group A: n=214 (52.04%); Group B: n=17 (45.95%); Group C: n=13 (81.25%); 
Group D: n=100 (69.93%): Group E: n=106 (75.18%); Group F: n=51 (64.56%).  
Figure 2.7 Age distribution according to sex for ages five and 
above (Groups C to F).  
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Table 2.7 Cause of death for all age groups in 2013 
Age Group A Group B Group C Group D Group E Group F 
 Infants 1 to 5 yr 6 to 17 yr 18 to 40 yr 41 to 60 yr 61+ yr 
Cause of death n (%) n (%) n (%) n (%) n (%) n (%) 
Respiratory 
infection 
163(86.53) 12(63.16) 6 (60.0) 47(70.15) 74(85.06) 36(73.47) 
Gastroenteritis 15(7.77) 3(15.79) 1 (10.0) 3(4.48) 4(4.60) 2(4.08) 
Both of the above 7(3.63) 1(5.26)  1(1.49)   
Meningitis 3(1.55) 1(5.26) 1(10.0) 7(10.45) 3(3.45) 1(2.04) 
Sepsis 1(0.52) 1(5.26) 1(10.0) 5(7.46) 2(2.30) 9(18.37) 
Other  
Acute myocarditis   1(10.0))    
Food poisoning     1(1.15)  
Gangrenous 
cholecystitis 
    2(2.30)  
Hydatid cyst    1(1.49)   
Meningitis & 
pneumonia 
 1(5.26)     
Necrotising 
fasciitis 
    1(1.15)  
Neurocysticercosis    2(2.99)   
Phlegmonous 
colitis 
     1(2.04) 
Ruptured colonic 
diverticular 
abscess 
   1(1.49)   
 
Table 2.8 Cause of death for all age groups in 2014 
 Group A Group B Group C Group D Group E Group F 
 Infants 1 to 5 yr 6 to 17 yr 18 to 40 yr 41 to 60 yr 61+ yr 
Cause of death n (%) n (%) n (%) n (%) n (%) n (%) 
Respiratory 
infection 
160(80.40) 11(61.11) 2(33.33) 52(68.42) 45(83.33) 26(86.67) 
Gastroenteritis 17(8.54) 5(27.78) 1(16.67)  1(1.85)  
Both of the above 7(3.52)      
Meningitis 3(1.51) 1(5.56)  8(10.53) 2(3.70)  
Sepsis 10(5.03)  3(50.0) 8(10.53) 3(5.56) 3(10.00) 
Other  
Bullous impetigo 1(0.50)      
Disseminated 
herpes 
     1(3.33) 
Disseminated TB  1(5.56)  5(6.58) 3(5.56)  
Myocarditis    1(1.32)   
Pericarditis    2(2.63)   
An external examination (EE) included the use of the Lodox® (Xmplar-dr) X-ray 
imaging system. In the majority of cases an EE was performed, with the exception of 
Group C (n=16), where 43.8% (n=7) received an EE and 56.2% (n=9) a full autopsy 
(FA). A partial autopsy (PA) was performed in a limited number of cases (Fig. 2.5).  
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Ancillary investigations were performed on 42 (21.1%) of the deceased infants 
(Group A) in 2014, and 38 (19.7%) in 2013. In 2014, 20 cases (10.1%) yielded a 
resultant pathogen and in 2013, 21 (10.9%) cases yielded a pathogen. In Group B 
(one to five years) microbiological analysis was requested once in 2014 and twice in 
2013, all yielded pathogens (section 2.3.4).  
Ancillary investigations were performed in 38 (17.8%) cases in 2013 and in 29 
(17.5%) cases in 2014 in Groups C to F (individuals older than six years). For each 
year, 19 (8.9% in 2014; 11.4% in 2014) cases yielded a pathogen (section 2.3.4). 
The pathogens identified coincided with the major post-mortem findings and could be 
considered the causative pathogenic agent.   
2.3.3 Risk factors and circumstances of death 
Group A and B 
Risk factors for deaths in infants and young children (one to five) differed from those 
recorded for individuals older than five years (Appendix C, supplementary material). 
The major risk factors identified for Group A and B were: sleeping position, co-
sleeping, prematurity, second-hand smoke exposure and a history of a previous 
infant that died suddenly and unexpectedly (Table 2.3). Over the two year period, 
51% (n=200) of infants were routinely put to bed on their side and 32.4% (n=127) in 
Figure 2.8 Percentage (%) of cases in each age group receiving either an external examination (EE), full 
autopsy (FA) or partial autopsy (PA). Group A: EE=68.8%; FA=28.1%; PA=3.1%. Group B: EE=67.6%; 
FA=29.7%; PA=2.7%. Group C: EE=43.8%; FA=56.2%. Group D: EE=58.7%; FA=38.5%; PA=2.8%. 
Group E: EE=78.7%; FA=19.9%; PA=1.4%. Group F: EE=62.0%; FA=35.4%; PA=2.6%.  
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the prone sleeping position. In addition, 44.9% (n=176) of infants co-slept with more 
than one person.  
 
Table 2.9 Risk factors identified for infants ≤1 year (Group A) and young children between one 
and five years (Group B) 
  2013 2014 
 
Group A Group B Group A Group B 
Risk factor 
N (%) 
 
N (%) 
 
N (%) 
 
N (%) 
 Sleeping position 
Side* 100(51.8) 10(52.6) 100(50.3) 9(50.0) 
Supine 14(7.3) 4(21.1) 27(13.6) 4(22.2) 
Prone 65(33.7) 1(5.3) 62(31.2) 2(11.1) 
Unknown 14(7.3) 4(21.1) 10(5.0) 3(16.7) 
Co-sleeping         
No 11(5.7) 2(10.5) 6(3.0) 2(11.1) 
Yes (1 other person) 99(51.3) 5(26.3) 80(40.2) 9(50.0) 
More than one person 71(36.8) 9(47.4) 105(52.8) 5(27.8) 
Unknown 12(6.2) 3(15.8) 8(4.0) 2(11.1) 
Prematurity         
Yes 60(31.1) 1(5.3) 71(35.7) 2(11.1) 
No 117(60.6) 14(73.7) 114(57.3) 13(72.2) 
Unknown 16(8.3) 4(21.1) 14(7.0) 3(16.7) 
Second-hand smoke exposure         
Yes 65(33.7) 3(15.8) 57(28.6) 1(5.6) 
No 68(35.2) 8(42.1) 116(58.3) 15(83.3) 
Unknown 60(31.1) 8(42.1) 26(13.1) 2(11.1) 
Previous SUDI         
Yes 19(9.8) 4(21.1) 39(19.6) 8(44.4) 
No 163(84.5) 11(57.9) 135(67.8) 9(50.0) 
Unknown 11(5.7) 4(21.1) 25(12.6) 1(5.6) 
*p<0.0001 
  
 
There was a significant association between sleeping position and the number of 
people in the bed (p<0.0001), with 49.2% (n=193) of infants side sleeping with at 
least one other individual in the bed.  
 
Infant deaths peaked during the winter months of June to August, with approximately 
equal percentages during the change of season during spring and autumn (Fig. 2.6).  
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There was a significant association between the month in which the infant died and 
the sex of the infant (p=0.013). Where 10.97% (n=43) of males demised in June and 
only 4.85% (n=19) of females in the same month. A similar trend could be seen in 
December where there were 6.12% (n=24) male deaths and 1.79% (n=7) female 
deaths (Fig. 2.7).  
 
 
 
 
 
 
 
 
 
 
 
Group C to F 
The main risk factors identified for individuals above the age of six were a history of 
co-morbid conditions and substance abuse. Over the two year period, a total of 
49.1% (n=186) of individuals older than six years had a history of co-morbid 
conditions that could predispose to infectious diseases. These conditions included 
hypertension, diabetes, tuberculosis, asthma and HIV. Of those that reportedly had a 
Figure 2.10 Total number of infant death cases by sex (Group A) per month of the year (p=0.013). 
Figure 2.9 Infant deaths for December 2013 to November 2014 (n=190) according to 
season. Summer: 17.4%. Autumn: 23.7%. Winter: 34.2%. Spring: 24.7%. 
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co-morbid condition, a total of 41.2% (n=95) had tuberculosis. A total of 20.1% 
(n=66) of individuals reportedly abused alcohol. In addition, some of these 
individuals abused other drugs, although in many cases the specific drug was not 
mentioned. In 7.4% (n=28) the specific illicit substance was reported (Table 2.6).  
 
 
Table 2.10 Group C to F (older than six years): Clinical information, circumstances of death 
and reported substance abuse 
 2014 N (%) 2013 N (%) 
Co-morbid condition   
Yes 84(51.5) 102(47.9) 
No 41(25.1) 62(29.1) 
Unknown 38(23.3) 49(23.0) 
TB 53(41.2) 42(41.2) 
Medication   
None 39(23.9) 51(23.9) 
Over the counter 5(3.1) 9(4.2) 
Prescription 27(16.6) 29(13.6) 
Chronic 38(23.3) 37(17.4) 
Traditional 1(0.6) 3(1.4) 
Unknown 53(32.5) 84(39.4) 
   
Circumstances of death   
Sleeping/At rest 44(27.0) 53(24.9) 
Daily activities 66(40.5) 92(43.2) 
Hospital 21(12.9) 15(7.0) 
Exercise/Physical altercation 2(1.2) 3(1.4) 
Other 8(4.9) 10(4.7) 
Unknown 22(13.5) 14(18.8) 
   
Reported substance abuse   
Alcohola 32(19.6) 44(20.7) 
Other drugs (incl. Tik, Mandrax, 
Marijuana, Unga and Heroin) 15(9.2) 13(6.1) 
None 53(32.5) 50(23.5) 
Unknown 65(39.9) 105(49.3) 
a The results for alcohol abuse include individuals reported to have abused other drugs 
 
A total of 39.3% (n=149) of individuals took some form of medication in the peri-
mortem period and a total of 19.8% (n=75) were taking chronic medication. In 41.7% 
(n=158) of cases the individual was performing a daily activity before death and in 
25.6% (n=97) of cases the individual was discovered to have passed away during 
their sleep or whilst being at rest (Table 2.4).  
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2.3.4 Case series description - pathogens and associated risk factors  
As reported in section 2.3.2 there were cases in each age group where a specific 
pathogen was identified. Of the 809 cases in the study, there were positive 
microbiological tests in 82 (10.14%). The demographic details of the case, 
pathogens and associated risk factors are set out in Appendix B (Tables B2.11-
B2.15).  
In total there were 94 pathogens identified. In eight cases more than one pathogen 
was detected. Bacterial pathogens (n=75, 79.8%) were detected in the majority of 
cases, followed by viral (n=5, 5.4%) and fungal pathogens (n=5, 5.4%). In two cases 
(2.1%) the tape worm, Taenia solium was identified. In all cases where a pathogen 
was detected the individual displayed one or more risk factors associated with that 
age group (Appendix B, Tables B2.11-B2.15). 
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2.4 Discussion 
The aim of this study was to assess variables associated with death due to infection. 
From which, identified risk factors in conjunction with the extent of the autopsy and 
ancillary investigations, were analysed. Many of the variables collected had an 
“unknown” option which indicated that the information was not contained in the case 
file. This is a limiting factor with regards to data analysis, and unfortunately, a 
general characteristic of retrospective studies. However, there were a total of 82 
(10.14%) cases over the two year period in which a pathogen was identified, which 
coincided with the major post-mortem findings. In these cases risk factors were 
identified and described.  
2.4.1 Age and sex distribution  
For infants (Group A) the highest number of deaths occurred from zero to three 
months (Fig 2.1). This is in contrast to literature from developed countries which 
suggest less frequent sudden death rates during the first month of life and a peak 
between two to four months [162]. In Group B (one to five years) the highest number 
of cases over both years occurred from one to two years of age. In Groups C to F 
(older than six years), the median age for males remained 46 years in both years 
whilst the median age for females declined from 52 years in 2013 to 38 years in 
2014 (section 2.3.1).  
Male sex has been identified as a risk factor for sudden infant death in several 
studies [84,86,163,164]. In this cohort, there was a 10% difference between male 
(55%) versus female (45%) infant deaths (Fig. 2.3 and 2.4). This coincides with the 
difference seen between male and female infants at five large medico-legal 
mortuaries in South Africa [159]. It has been suggested that an increase in 
testosterone levels during the first months of life is associated with lower levels of 
pro-inflammatory cytokines. Production of these cytokines is also reduced in the 
presence of tobacco smoke [95,111].  
There was a marked increase in the percentage of males (64.5%-81.3%) in the older 
age categories (Groups C to F) compared to females. These figures correspond to a 
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similar study carried out at a medico-legal mortuary in South Africa where sudden 
death in adults over a five year period was investigated [148]. However, the 
underlying vulnerability of male sex in adults towards infection has only been 
discussed in literature under hypotheses. This includes the hypothesis that 
hemizygous males lack the protective measure of a second X-chromosome [96] 
which contains the majority of immune system related genes [121].   
 
2.4.2 Identified risk factors  
The sudden unexpected death of an infant (SUDI) rate in some areas of Cape Town 
has been estimated to be amongst the highest in the world [28]. Reasons behind this 
high rate of infant mortality need to be assessed, specifically with regards to risk 
factors in vulnerable populations. In this study, an average of 51% of infants were 
put to bed on their side and 32.5% on their stomach (Table 2.3). The prone sleeping 
position is a well-known risk factor for SUDI with an associated infectious aetiology 
[83]. Many infant death (or “cot death”) prevention campaigns world-wide have seen 
a decrease in infant deaths, following the recommendation that infants be put to 
sleep on their back [165].  
 
In South Africa there are many informal settlements with associated low 
socioeconomic status (SES) and crowded living environments. An average of 
56.21% (n=241) of infants and children, between one and five years, reportedly lived 
in informal housing (Appendix B, Fig. B2.11). It has been shown that low SES not 
only serves as a mediator, but can be an independent risk factor for SUDI. This may 
be due to low SES being a proxy for limited access to healthcare and inadequate 
protection from natural elements [166].  Some of the areas that Salt River Mortuary 
services include large informal settlements, where co-sleeping with more than one 
person remains a common phenomenon. There was a significant association 
between co-sleeping and sleeping position (p<0.0001), with 49.2% (n=192) of infants 
put to bed on their side whilst co-sleeping (Table 2.3). This leads to the deduction 
that the side sleeping position of the infant is perhaps due to lack of space in the 
sleeping environment. In this sleeping position, the face of the infant would still be in 
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contact with a mattress, cushion or person. Thus side sleeping could belong to the 
continuum that reflects the hypothesis behind the risk factor of prone sleeping.  
 
In addition, established risk factors such as prematurity (33.4%) and exposure to 
tobacco smoke (31.2%) were also identified (Table 2.3). Maternal smoking in the 
prenatal, perinatal and postnatal periods have been associated with an increased 
risk for SUDI [86]. It has also been shown that this risk increases significantly when 
co-sleeping occurs in conjunction with exposure to tobacco smoke [85]. These risk 
factors were present in very high proportions in this cohort and indicate the need for 
educational campaigns regarding risk factors associated with infant mortality. Of 
much concern is the increased history of previous SUDI (Table 2.3) from 2013 
(9.8%) to 2014 (19.8%). As the total amount of cases in this age category is similar 
in both years (n=193 in 2013 and n=199 in 2014) it would be beneficial to continue 
monitoring these rates in order to determine if there is indeed an upward trend.  
 
A significant association was found (p=0.013) between sex and month of the year for 
infant deaths (Group A). During the month of June there was approximately twice the 
percentage of male (10.97%) deaths compared to female (4.85%) deaths (Fig. 2.10). 
It can be hypothesised that the risk factors of seasonality [10,145,167] (winter and 
summer) and the sub-optimal immune system of male infants (in particular those 
under 3 months of age) intersect to significantly increase the risk of infection and 
sudden death in these infants. 
Co-morbid conditions were reported for 49.1% (n=186) of individuals in Groups C to 
F (older than six years). Of these, TB was reported in 41.2% (n=95) of cases (Table 
2.4). In the year 2013 and 2014, the incidence of TB was estimated to be 292 (260-
325) and 281 (250-313), respectively, per 100 000 population in Africa [168]. 
Although the largest number of new cases occurred in South-East Asia, Africa 
carried the highest burden of disease in 2014. TB remains a major health concern in 
the developing world  with South Africa having the third highest incidence rate (802.2 
per 100 000 population) after India and China [82]. In this cohort a total of 34.04% 
(n=129) individuals above the age of six were reported to either have pulmonary or 
disseminated TB precipitating or causing the death of the individual. Recently, the 
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sudden death of an apparently healthy 35-year old male due to a TB infection of the 
myocardium presented at a medico-legal mortuary in South Africa [81]. This case 
highlights the variety of ways in which death due to TB can manifest and the 
importance of this infection in the forensic setting.    
Genetic variations have been studied in immune system related genes in infants 
[97,110,169]. However, there may be variants which could predispose to infection an 
individual throughout their lifetime. One such group of inherited disorders is Primary 
Immunodeficiency Disorders (PID). There are approximately 250 different types of 
PIDs, of which over 100 have been characterised at the genetic level [113].  
Recently, concern has been raised regarding the under-reporting of PIDs in South 
Africa in disadvantaged areas. Clinical warning signs include severe and recurrent 
infections and in the case of infants, a mother who had a previous infant SUDI as a 
result of infection [114].   
Molecular autopsies can be defined as post-mortem genetic testing in order to 
establish a cause of death in the case of negative autopsy findings. Molecular 
autopsies investigating the genetic variations associated with the risk for sudden 
cardiac death in young have been explored extensively in the literature [170–172]. 
Apart from variations in immune system related genes in infants [98,102,173–175], 
the role of genetic variants predisposing an individual to infection and subsequent 
sudden death have not yet been studied.  
 
2.4.3 Ancillary investigations and post-mortem microbiology 
Post-mortem microbiological analysis has been a contentious subject for many years 
[176,177]. As discussed in a review article by Tsokos et al. (2001) there is wide-
spread belief that the large amount of positive cultures found in post-mortem cases 
is associated with bacterial invasion following death and some suggest inadequate 
sampling and handling procedures [178]. Although there is debate regarding 
interpretation of post-mortem microbiology, it has been shown that as few as 10% of 
positive cultures may be due to post-mortem bacterial translocation [64]. With the 
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use of molecular techniques it was shown that the liver and pericardial fluid remain 
the most sterile sites for sampling (up to 5 days post-mortem) and these techniques 
(such as RT-qPCR) may be used to detect normally uncultivable infectious 
pathogens [179]. Interpretation of microbiological results should however be 
conducted holistically in order to correctly identify possible pathogens in infectious 
deaths. Nevertheless, there is value in performing post-mortem microbiological 
testing in a forensic setting, where often ante-mortem clinical information is 
unavailable [64,180,181].  At Salt River Mortuary and at local South African Police 
Service (SAPS) stations there are questionnaires that are completed in the case of a 
sudden unexpected or unexplained death (Appendix C). In the absence of a clinical 
history the information obtained from these may be used to direct investigations and 
support the causative role of a pathogen. In addition, these questionnaires could 
form part of, or be used as the basis of a standardised protocol at medico-legal 
mortuaries.   
However, in the majority of the cases included in this study ancillary investigations 
were not performed (section 2.3.2). A South African forensic pathologist is not 
mandated by law  to investigate a death deemed natural [4]. Thus, the value of 
performing additional investigations needs to be critically assessed, particularly with 
regards to scarcity of resources. With this in mind, a standardised protocol might aid 
in uniformly directing the death investigation to not only establish cause of death but 
allow for the optimal allocation of resources.  
The alarming number of infant death cases that are due to infections should be 
investigated further in a local context. Post-mortem bacteriology and virology is a 
valuable tool in elucidating SUDI [158] [10] and provides a mechanism by which 
SIDS cases can be differentiated [10]. Although the interpretation of positive 
microbiological cultures in infant death cases remain difficult, it has been shown that 
there is no association between a post-mortem interval (PMI) of several days and the 
translocation of micro-organisms [182]. In this cohort it is thus possible that the 
pathogens cultured from normally sterile sites can be seen as causative in the 
majority of cases.  
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In South Africa, up to 50% of deaths in children (between one and five) are due to 
natural causes [139]. One of the reasons behind the establishment of the Child 
Death Review (CDR) in 2014 was to address the gaps that are identified when an 
infant dies of a natural cause. One discussion point is whether an individual or 
system might still be at fault [183]. Can these deaths be classified as unnatural due 
to omission/co-mission of administering proper care? And if so would ancillary 
investigations, such as microbiology, virology, histology and pharmacology, add 
value to social or possible judicial intervention?  [156]. Thus the CDR is a valuable 
tool in the forensic setting, of the local community, and represents a platform from 
which protocols can be derived.  
A large multi-centre study regarding SUDI investigation protocols in South Africa 
highlighted the high degree of variation that exists within and between medico-legal 
facilities [184]. Medico-legal mortuaries attached to an academic institution may have 
the capacity to implement standardised protocols, and baseline data for five such 
South African mortuaries already exist [159].  
 
2.4.4 Types of infection and related pathogens 
Streptococcus pneumoniae was isolated in 12 cases where death was due to 
pneumonia or meningitis. Of the cases where a pathogen was identified for 
meningitis, Neisseria meningitidis was only isolated once, with the rest (n=7) 
associated with S. pneumoniae. Bacterial meningitis has been shown to be widely 
caused by N. meningitidis and S. pneumoniae [185].  
Staphylococcus aureus was the second most prevalent pathogen identified (n=11). 
These bacteria have long been associated with infant death due to infectious 
diseases [11,22,94]. The oldest individual in this cohort where S. aureus was 
isolated was ten years old with the cause of death recorded as sepsis.   
Staphylococci can be classified into two main groups, coagulase positive and 
coagulase negative. The most prevalent pathogenic coagulase negative 
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staphylococcus bacterium is Staphylococcus epidermidis which is the most 
commonly associated pathogen for nosocomial infections in the developed world. 
Therefore immunocompromised individuals are susceptible to this pathogen. This 
pathogen also has the potential for biofilm formation and can colonise a variety of 
surfaces [186]. In 2013 and 2014, this pathogen was only associated with respiratory 
infections in infants (Appendix B, Tables B.2.11 and B.2.12), with one case of brain 
pathology resulting in hydrocephalus (2014) in a 16 year old male (Table B.2.15) and 
with meningitis in a two year old female (2013) (Table B.2.13). In all infants where 
this pathogen was identified the infant was routinely put to sleep in the prone position 
(Tables B.2.11 and B.2.12) which may suggest colonisation occurs subsequent to 
contact with bedding potentially acting as a reservoir.  
The tape worm, T. solium was identified in two cases in this cohort and cause of 
death was given as neurocystericercosis (Table B.2.4). Neurocysticercosis is the 
leading cause of parasitic central nervous system infection in the world and is one of 
the leading zoonotic diseases in developing countries [187]. It is also the leading 
cause of acquired epilepsy and is emerging as a serious health concern in 
developing countries including, Tanzania, Zambia and Mozambique [188–190].  
Many of the pathogens identified in this cohort colonise, and may become lethal in 
immunocompromised individuals. As the majority of these deaths occurred out of 
hospital, and the infection is not nosocomial in nature, the immune status of the 
vulnerable population needs to be assessed. HIV infection in South Africa is still a 
major concern [191] and leads to the affected individual becoming 
immunocompromised. It has been shown that innate immune system development of 
HIV exposed infants is compromised during the early stages of life [192]. This 
increases the infant’s risk for death due to infectious diseases [193]. In addition, it 
was shown that there is a high prevalence of HIV infection (43%) in sudden 
unexpected deaths of adults at a South African medico-legal mortuary [194]. HIV 
infection in these cases was 17% higher (p=0045) than the general population of the 
mortuary [194]. Thus the prevalence of HIV exposure in infants and the HIV status in 
older individuals in the mortuary setting could explain why opportunistic pathogens 
lead to sudden or unexplained death. However, in this cohort the role of HIV infection 
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cannot be assessed as it is not routinely screened for in cases at Salt River 
Mortuary. 
Risk factors were identified in all cases of infant death where a pathogen was found. 
One such risk factor is the vaccination status of the infant. Whether an infant is ‘up-
to-date’ with their vaccine schedule could possibly pose a means for the infant to 
become immunocompromised. Out of the 44 infant and children (under five) cases in 
which a pathogen was identified, seven (15.9%) where not ‘up-to-date’ with their 
vaccine schedule as per the “Road to Health Card”. However, in 15 (34.1%) cases it 
was unknown whether the infant had received their most recent vaccine or not. 
Although, of those seven cases in which the deceased was not ‘up-to-date’, other 
recognised risk factors were identified and the contribution of the vaccination status 
should not be assessed in isolation. 
 
2.4.5 Cause of death and extent of autopsy 
The leading causes of death (i.e. sudden and unexpected death resulting in a 
medico-legal autopsy) in all age categories, for both years, were respiratory 
infections (Tables 2.1 and 2.2). This corresponds with both local [28,148,156], 
African [153] and international studies [9]. In addition, respiratory infections, including 
pneumonia, in infants and young children  have been shown to be highly prevalent in 
the Western Cape [157,195]. This was followed by gastroenteritis, meningitis and 
sepsis. 
 
Despite the high prevalence of respiratory infections in the Western Cape, only 
10.5% (n=41) of all infant death cases in this cohort had a pathogen identified. This 
percentage is mainly attributed to many cases only receiving an external 
examination (including X-ray imaging) (Fig. 2.5 and Tables 2.1 and 2.2). Information 
on specific pathogens identified would be useful in order to monitor antibiotic 
resistance, emerging and re-emerging pathogens, vaccination schedules and the 
identification of ‘at-risk’ communities.  
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In the older age groups (age six and above) deaths were also mainly attributed to 
respiratory infections. The majority of these (74.93%, n=284) occurred from the ages 
18 to 60 (Group D and E) which has mostly been associated with sudden cardiac, as 
opposed to infection related death in the literature [147,196–198]. Sudden cardiac 
deaths usually occur secondary to cardiac channelopathies with an underlying 
genetic predisposition [170,199]. Thereby, reiterating the need for and value of a 
standardised protocol in South Africa. This may eventually lead to the inclusion of a 
molecular autopsy in the case of negative autopsy findings.   
There exists the possibility that respiratory infections are incidental findings in the 
death of an individual. In this cohort, many of the deaths of individuals older than six 
did not receive a full autopsy and thus it is uncertain whether the respiratory infection 
as seen on X-ray was the primary cause of death. Much literature exists which 
stresses the importance of microbiological analysis before concluding infection as a 
cause of death [53,63,133,185,200,201]. Therefore, the possibility exists that the 
percentage of deaths due to respiratory infections is lower than reported here.  
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2.5 Conclusion 
There was a significant association (p=0.013) between sex and the month in which 
an infant dies, with approximately twice the number of male deaths as compared to 
female deaths during June and a similar trend in December. In addition, a male 
excess was seen in all age groups in this study, particularly in Groups C to F (older 
than six years). This supports the hypothesis that being male is a risk factor for 
infection and/or sudden unexpected death throughout life.  
The side sleeping position of infants (Group A) was significantly associated 
(p<0.0001) with co-sleeping. This emphasises the need for local research to identify 
relevant risk factors and indicates the value of ongoing educational campaigns 
directed towards infant caregivers on the risks posed by the sleeping environment of 
the infant.  
The presence of risk factors such as co-sleeping, exposure to tobacco smoke and 
the side or prone sleeping position might distinguish the self-limiting respiratory 
infections from fatal infectious events in infants. Therefore, when a caregiver 
presents an infant with a mild respiratory infection to a healthcare facility it is 
important to establish the presence of these risk factors within the household 
environment. 
Tuberculosis remains a major health concern and it would be beneficial to further 
study the immune status of individuals receiving a medico-legal autopsy and whose 
cause of death is associated with tuberculosis. This will further the understanding of 
how immunocompromised individuals are vulnerable to acute and/or aggressive 
infections leading to sudden death.  
The influence of genetic variants which could predispose an individual toward 
infections would further the understanding of this subject. This is in line with recent 
international trends towards molecular autopsies. These variations have been 
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studied in immune system related genes in infants; however there may be variants 
which could predispose an individual throughout their lifetime. In addition, molecular 
autopsies could delineate whether the sudden death of an individual was due to a 
genetic cardiac related event or other extraneous factors such as infection.   
In the majority of cases the cause of death was a respiratory infection. This might be 
a true reflection with regards to infant deaths and an over-estimation in older age 
groups. A standardised protocol into the investigation of these deaths would allow 
information to be shared between mortuaries and can further be directed into the 
healthcare system. An accurate reflection of not only cause of death, but also the 
prevalence of pathogens at medico-legal mortuaries would be beneficial for 
communities in South Africa.  
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Table A.1.2 Scopus search terms 
Terms used in the meta-search of the Scopus Database 
(( ( ( ( ( ( TITLE-ABS-KEY ( "sudden death" )  AND  TITLE-ABS-KEY ( infection )  
OR  TITLE-ABS-KEY ( "sudden unexpected death" ) )  AND  PUBYEAR  >  1999 
)  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND  TITLE-ABS-KEY ( infection 
)  OR  TITLE-ABS-KEY ( virus )  OR  TITLE-ABS-KEY ( bacteria )  OR  TITLE-
ABS-KEY ( pathogen )  OR  TITLE-ABS-KEY ( zoonotic ) )  AND  PUBYEAR  >  
1999 )  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND NOT  TITLE-ABS-KEY 
( cardiac )  AND NOT  TITLE-ABS-KEY ( iatrogenic )  AND NOT  TITLE-ABS-KEY 
( chronic )  AND NOT  TITLE-ABS-KEY ( hospital )  AND NOT  TITLE-ABS-KEY ( 
diagnosis )  AND NOT  TITLE-ABS-KEY ( prognosis )  AND NOT  TITLE-ABS-
KEY ( mouse )  AND NOT  TITLE-ABS-KEY ( dog ) )  AND  PUBYEAR  >  1999 )  
AND  ( ( ( TITLE-ABS-KEY ( "sudden death" )  AND  TITLE-ABS-KEY ( infection 
)  OR  TITLE-ABS-KEY ( "sudden unexpected death" ) )  AND  PUBYEAR  >  
1999 )  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND  TITLE-ABS-KEY ( 
infection )  OR  TITLE-ABS-KEY ( virus )  OR  TITLE-ABS-KEY ( bacteria )  OR  
TITLE-ABS-KEY ( pathogen )  OR  TITLE-ABS-KEY ( zoonotic ) )  AND  
PUBYEAR  >  1999 )  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND NOT  
TITLE-ABS-KEY ( cardiac )  AND NOT  TITLE-ABS-KEY ( iatrogenic )  AND NOT  
TITLE-ABS-KEY ( chronic )  AND NOT  TITLE-ABS-KEY ( hospital )  AND NOT  
TITLE-ABS-KEY ( diagnosis )  AND NOT  TITLE-ABS-KEY ( prognosis )  AND 
NOT  TITLE-ABS-KEY ( mouse )  AND NOT  TITLE-ABS-KEY ( dog ) )  AND  
PUBYEAR  >  1999 ) )  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND NOT  
TITLE-ABS-KEY ( idiopathic ) )  AND  PUBYEAR  >  1999 )  AND  ( ( TITLE-ABS-
KEY ( "sudden death" )  OR  TITLE-ABS-KEY ( forensic )  OR  TITLE-ABS-KEY ( 
medico-legal )  OR  TITLE-ABS-KEY ( autopsy ) )  AND  PUBYEAR  >  1999 ) )  
AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND NOT  TITLE-ABS-KEY ( pigs )  
AND NOT  TITLE-ABS-KEY ( porcine )  AND NOT  TITLE-ABS-KEY ( treatment ) 
)  AND  PUBYEAR  >  1999 ) )  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND 
NOT  TITLE-ABS-KEY ( plant )  AND NOT  TITLE-ABS-KEY ( neuropathy ) )  
AND  PUBYEAR  >  1999 ) )  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND 
NOT  TITLE-ABS-KEY ( sickle  cell )  AND NOT  TITLE-ABS-KEY ( cancer )  AND 
NOT  TITLE-ABS-KEY ( carcinoma )  AND NOT  TITLE-ABS-KEY ( complic* ) )  
AND  PUBYEAR  >  1999 ) )  AND  ( ( TITLE-ABS-KEY ( "sudden death" )  AND 
NOT  TITLE-ABS-KEY ( epilepsy )  AND NOT  TITLE-ABS-KEY ( sudep )  AND 
NOT  TITLE-ABS-KEY ( congenital ) )  AND  PUBYEAR  >  1999 ) )  AND  ( ( 
TITLE-ABS-KEY ( "sudden death" )  AND NOT  TITLE-ABS-KEY ( cattle ) )  AND  
PUBYEAR  >  1999 )  AND  ( LIMIT-TO ( SUBJAREA ,  "MEDI" )  OR  LIMIT-TO ( 
SUBJAREA ,  "IMMU" )  OR  LIMIT-TO ( SUBJAREA ,  "BIOC" )  OR  LIMIT-TO ( 
SUBJAREA ,  "PHAR" )  OR  LIMIT-TO ( SUBJAREA ,  "SOCI" )  OR  LIMIT-TO ( 
SUBJAREA ,  "NEUR" )  OR  LIMIT-TO ( SUBJAREA ,  "NURS" ) )  AND  ( LIMIT-
TO ( LANGUAGE ,  "English" ) ) 
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Appendix B 
Section B.1.1 Variable definitions 
Housing: Informal, Formal, Other, None, Unknown. 
Housing was recorded as it was reported within the case file. If the type of housing 
was not recorded in the case file but an address or GPS coordinates for the area of 
death was provided this was used to look up the type of housing. Informal housing 
was defined as a ‘makeshift dwelling not constructed from typical building materials 
and/or which has no indoor plumbing and/or no electricity supply’. Formal housing 
was defined as a building or structure that has been constructed from approved 
building materials. ‘Other’ housing was defined as housing which, although not 
formal in nature still provide a form of shelter from the elements and which may or 
may not have plumbing or electricity, e.g. a ‘Wendy House’ attached to a formal 
dwelling. The ‘None’ category was assigned if the person was a recorded as a 
known vagrant. If there was no information on housing in any of the documents 
provided in the case file it was assigned to ‘unknown’ category.  
Extent of autopsy: External examination, partial autopsy, full autopsy. 
An external examination involved the use of the Lodox® (Xmplar-dr) X-ray imaging 
system. This type of examination did not include the internal examination of organs 
and thus no histology or microbiological analyses were performed. A full autopsy 
was defined as the internal examination of organs and tissues in a defined and 
systematic manner. This type of autopsy allows for tissue and other samples to be 
taken at the discretion of the forensic pathologist. A partial autopsy was defined as 
the internal examination of only a certain body compartment or organ at the 
discretion of the forensic pathologist.  
Medication: None, Chronic, Over the Counter, Prescription, Traditional, Unknown. 
Information regarding the type of medication the individual received was retrieved 
either from the information supplied by a family member (recorded in the case file) or 
from clinical documents attached to the case file (e.g. doctors notes). If it was stated 
that no medication was taken by the deceased this was recorded as none. If the 
information was not recorded (i.e. missing information) this was recorded as 
unknown. Chronic medication included prescription medication taken over a period 
of time for a chronic disease, disorder or condition (e.g. hypertension, diabetes, anti-
retrovirals).  Over the counter medication was defined as medication that the 
deceased purchased at a pharmacy or convenience store which require no doctor’s 
prescription (e.g. Aspirin, Paracetamol). Prescription medication was defined as that 
which the deceased received as a result of a doctor’s visit and which could not 
otherwise have been obtained (e.g. anti-biotics). Traditional medication was noted if 
the family member explicitly stated that the deceased had taken such medication.  
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Circumstances of death: Daily activity, Sleeping, At rest, Exercise, Physical 
altercation, Other, Unknown, Hospital.  
A daily activity was defined as the deceased being ambulatory with cognitive function 
(as witnessed by another) moments before death (e.g. walking to the bathroom). 
Sleeping was defined as the deceased being discovered in a normal sleeping 
environment for that individual. At rest was defined as the individual being 
discovered in a resting position, such as on a couch. Exercise was defined as the 
deceased being involved in strenuous activity moments before death. Physical 
altercation was recorded if witnessed as such by another. Other circumstances 
included an activity which did not adhere to the any of the other circumstances. 
Unknown circumstances were recorded if no information on this variable could be 
derived from the case file. Hospital deaths were recorded separately in order to 
distinguish these from individuals demising at rest or sleeping out of hospital.  
All other variables were part of and defined in the standard questionnaires attached 
to the case
Figure B2.12 Housing according to age group
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Appendix C 
 
 Ethics approval 
 Contemporaneous Note (Lab. 27): Salt River Forensic Pathology Laboratory” 
blank form  
 FPS006(b) blank form 
 FPS006(a) blank form 
 Supplementary material – Group A and B variables 
 Supplementary material – Group C to F variables 
25 February 2016 
HREC REF: 102/2016 
Miss L Heathfield 
UNIVERSITY OF CAPE TOWN 
Faculty of Health Sciences 
Human Research Ethics Committee 
Room E52-24 Old Main Building 
Groote Schuur Hospital 
Observatory 7925 
Telephone [021] 406 6338 • Facsimile [021] 406 6411 
Email: sumayah.ariefdien@uct.ac.za 
Website: www. health. uct.ac .za/fhs/research/humanethics/forrns 
Division of Forensic Medicine & Toxicology 
Level 5, Entrance 2 
Falmouth Building-FHS 
Dear Miss Heathfield 
PROJECT TITLE: THE PREVALENCE OF INFECTION RELATED DEATHS AT SALT RIVER 
MORTUARY IN THE WESTERN CAPE FROM 2010 TO 2014 (Mphil candidate- Maria Kruger) 
Thank you for submitting your study to the Faculty of Health Sciences Human Research Ethics 
Committee (HREC) for review. 
It is a pleasure to inform you that the HREC has formally approved the above-mentioned study. 
Approval is granted for one year until the 28 February 2017. 
Please submit a progress form, using the standardised Annual Report Form if the study continues 
beyond the approval period. Please submit a Standard Closure form if the study is completed within the 
approval period. 
(Forms can be found on our website: www.health.uct.ac.za/fhs/research/humanethics/forms) 
Please quote the HREC REF in all your correspondence. 
We acknowledge that the student, Maria Kruger will also be involved in this study. 
Please note that the ongoing ethical conduct of the study remains the responsibility of the principal 
investigator. 
Yours sincerely 
p PROFESSOR M BLOCKMAN 
CHAIRPERSON. FHS HUMAN RESEARCH ETHICS COMMITTEE 
Federal Wide Assu.rance Number: FWA00001637. 
Institutional Review Board (IRB) number: IRBOOOOl 938 
This serves to confirm that the University of Cape Town Human Research Ethics Committee complies 
to the Ethics Standards for Clinical Research with a new drug in patients, based on the Medical 
Research Council (MRC-SA), Food and Drug Administration (FDA-USA), International Convention on 
Harmonisation Good Clinical Practice (ICH GCP), South African Good Clinical Practice Guidelines (DoH 
HREC 102/2016 
2006), based on the Association of the British Pharmaceutical I ndustry Guidelines (ABPl),and 
Declaration of Helsinki (2013) guidelines. 
The Human Research Ethics Committee granting this approval is in compliance with the ICH 
Harmonised Tripartite Guidelines E6: Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) 
and FDA Code Federal Regulation Part 50, 56 and 312. 
HREC 102/2016 
CONTEMPORANEOUS NOTE (LAB. 27) : SALT RIVER FORENSIC PA THO LOGY LABORATORY 
WC/11/ _____ _ PATHOLOGIST ________ BODY BAG SEAL NO ________ _ 
ASSISTANT _________ _ DATE OF PM ________ _ TIME OF PM ____ _ 
l. RACE: jwhite 
2. GENDER: !Male 
4. NAME OF DECEASED: 
!Coloured 
Wemale 
I African 
3. AGE: 
!Asiatic l 
5. AREA OF DEA TH: 6. SAPS STATION:-----------
7. DATEOFDEATH: ___________ _ 8. TIME OF DEATH: _______ _ 
9. DIED IN: 
House Shack Road 
Swimmine nnn I Bucket/Bin Shebeen 
Hosoital Railway track Open land 
HISTORY ________________ _ 
EXTERNAL FEATURES ___________ _ 
CHIEF POST-MORTEM FINDINGS 
I. 
2. 
3. 
4. 
5. 
Dam River 
Sea Lake 
Toilet Other 
-\ /' 
CAUSE OF DEATH ________________ _ 
ALCOHOL SEAL NUMBERS Inner Outer 
Received bv: 
Exhibits received by: 
Photographer: 
Signature:----------
\VC/11/ ...........................•........................ 
I. HEIGHT WEIGHT 
2. IDENTIFYING FEATURES 
TEETH R M M M PM 
L 
R M M M PM 
L 
3. PM Changes: Rigor Mortis: 
T emperaturc: 
4. External Appearance 
5. Skull 
6. Brain 
7. Eyes: 
8. Mouth, tongue and pharynx 
9. Neck 
10. Thoracic cage 
11. Mediastinum 
12. Ain.vays 
13. Lungs 
14. Heart 
15. Large blood vessels 
16. Peritoneal cavity 
17. Stomach 
18. Intestines 
19. Liver 
20. Pancreas 
21. Spleen 
22. Adrenals 
23. Kidneys 
24. Bladder 
25. Pelvic Walls 
PHYSIQUE 
PM C C PM PM 
PM C C PM PM 
Arms/Legs/Mandible 
Ears: 
Urine: 
M M 
M M 
Contents 
NUTRITION 
M 
M 
Lividity 
Brain Mass: 
Nose: 
Mass: R 
Mass: L 
Mass: 
Mass: 
Mass: 
Mass: 
Mass: R 
Mass: L 
Mass: R 
Mass: L 
Clcar/turbulent/blood•stained 
26. Ge11italia: MALE: EXTERNAL PENIS:· Cit<iuncirc. SCROTUM INTERNAL: Testes 
Uterus/Ovaries 
Prostate 
FEMALE: External Internal 
27. Spinal Column 
28. Spinal Cord 
SPSCIMENS RETAINED 
I. Blood/Eye Fluid for alcohol Outer seal: Inner seal: 
2. Toxicology Outer seal: Inner seal; 
3. Histology 
ADDITIONAL SPECIMENS: 
I. 
2. 
3. 
4. 
  FPS006(b) 

   
FORENSIC PATHOLOGY SERVICE  
 
SUDI [Complete If A Baby Should Suddenly And Unexpectedly Die] 
 
FPS laboratory________________________________                     WC _______________________ 
 
Name of baby ________________________________ 
 
 
 
Section A. 
Who gives the history/ information in this case e.g. mother/father/granny/grandpa/other 
relative(give details) 
Name:                                                                                                Relationship: 
 
Address:                                                                                           Contact telephone number: 
 
 
ID Number: 
 
Infants full name:     
  
Home Address:        
 
                                                                            
Age of Baby 
    
Date of birth:   
Race:  
  
Sex: 
 
Section B 
Person(s) at/called to the scene and relationship 
Name/relationship Date Time 
 
Name/relationship Date Time 
 
Name/relationship Date Time 
 
Police response/name Date Time 
 
Paramedic response/name 
 
Date Time 
 
When was the death certified/by whom Date Time 
 
If the baby was taken to hospital 
 
  
Name of hospital 
 
	
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Date of arrival:                                                                                      Time of arrival: 
 
Name of doctor seen / declared death: 
 
Comment:  Get copies of doctors notes 
 
Was resuscitation done on the baby by the paramedic or the doctors at the hospital? 
 
Section C 
Household environment: 
Place where baby lives:                                                           house       shack       other –  
Number of bedrooms    
Is the room in which the baby is found well ventilated? 
Odour(s) present in the room the baby slept in?   Yes  No 
Peeling paint in the room the baby slept in?    Yes  No 
Fungal growth (mould) in the room the baby slept in?   Yes  No 
Did people smoke cigarettes in the room the baby slept?  Yes  No 
Are there pets in the house?   
If yes – type and number:     
 
 
Yes  No 
Did caregiver use alcohol or drugs on the night baby died?    Yes  No 
Was there a heater or open fire or galley blik or other  heating device in room where baby slept?  Yes  No 
In what position was the baby found lying?   
Has the baby been moved?   
Were there any covers/ clothing etc over the baby’s head?   
Was the baby squashed/wedged between anything (object)?   Yes  No 
Was there overlaying (someone lay on top of the baby)?      Yes  No 
Comments from forensic officer who attended the scene: 
 
 
 
 
 
  FPS006(b) 
WC__________________   
    
 
3 
 
 
 
 
Section D 
Circumstances of death / details about events before death 
 
1.  When was the baby last seen alive 
 
Date Time 
2.  Who last saw the baby alive 
 
  
3.  When was the baby found dead 
 
Date Time 
4.  Who found the baby dead at the scene 
 
  
5.  Was the baby ill?   
 
Yes No 
 
  a)  If yes – What was wrong and for how long? 
 
 
  b)  Was the baby taken to the doctor or pharmacy or clinic or traditional healer for the 
illness? 
        When (date and time)?   
 
Yes No 
  c)  If not, why not: 
 
  d)  Was the baby admitted to a hospital or clinic for the illness: 
When (date and time)? 
 
Yes No 
 e)  If not, do you know why not? 
 
  f)  What medication was given (names please  
 
 
6.  Where was the baby found dead Bed Couch Cot  Floor Other 
 
       Other: 
 
 
7.  Did the baby sustain any injuries – eg by falling or being hit: 
     If yes: 
Yes 
 
No 
 
    a)  When did it happen? 
 
   b)  How did it happen? 
 
 
  c)  Where did it happen? 
 
  d)  What did the caretaker do about it? 
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8.    a) On what was the baby placed to sleep Bed with a 
pillow 
Bed 
without a 
pillow 
Couch 
with a 
pillow 
Couch 
without pillow 
Cot with 
pillow 
 Cot 
without 
pillow 
Floor with 
pillow 
Floor 
without 
pillow 
Other  
b) If placed on a bed/cot, what was the mattress type Foam 
rubber 
Inner spring Other 
c)  Was the mattress covered with a blanket or sheet Yes No 
 
d)  What position was the baby placed when put to sleep? Back Stomach Side Other 
 
     Other -   
 
e)  what was used to cover the baby:  List items 
 
 
e)  What position was the baby found dead? Back  Stomach 
 
Side 
 
Other 
 
      Other –  
 
f)  Has the baby been moved? Yes No 
 
g)  Face position when the baby was found dead 
 
To the left To the right Face 
down 
 
 Face up Unknown 
 
 
h)  Face and or chest squashed / wedged between any object(s) when the 
baby was found dead? 
Yes No  Unknown 
 
If yes – details please –  
 
 
  
i)  Was the nose and mouth of the baby covered by anything – eg blankets 
or anything else 
Yes No  Unknown 
 
j)  Were there other items in contact with the baby – eg pillow Yes No Unknown 
 
k) Did the baby use a Dummy (pacifier)? Yes No 
 
l) Did the baby sleep in the same bed as the mother? 
 
Yes No 
 
m)  Did the baby sleep in her arms? 
 
Yes No 
 
n) Did the baby sleep on her chest? 
 
Yes No 
 
o)  Did the baby sleep with the mother on a couch? 
 
Yes 
 
No 
 
p)  How many other people slept on the same bed as the baby at the time the baby died?   
 
q)  Was anyone found on top of the baby while in the bed (Overlaying)? 
 
Yes No 
r)  Was the window where the baby slept on the day /night the baby died Open Closed 
 
s)  Did the mother or anyone in the house smoke while the baby slept on the night/day of 
death? 
 
  
t)  When was the baby last fed? Date Time 
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u)  Did the mother/caregiver use alcohol before going to bed with the baby on the 
night/day the baby was found dead? 
      If yes, how much? 
 
Yes No 
v)  Did the mother/caregiver use drugs before going to bed with the baby on the 
night/day the baby was found dead? 
     If yes, what drugs? 
 
Yes 
 
No 
w)  Did the mother/caregiver give the baby medication on the night/day of death? 
       If yes, name of medication:   
 
 
Yes No 
Section E 
About the baby 
 
1.  Where was the baby born? Hospital Clinic Home Other 
 
Name of hospital/clinic/other 
 
  
2.  How was the baby born? Normal 
vaginal 
delivery 
Caesarian 
section 
3.  How much did the baby weigh at birth? 
 
  
4.  Was the baby  Premature Full term Post dates 
(Overdue) 
5.  If the baby was premature, how premature was it? 
 
  
6.  Did the baby receive Kangaroo care (KMC) 
 
Yes No 
7.  Did the mother carry the baby on her back? 
 
Yes No 
8.  Was the baby  Breast fed Bottle/formula 
fed 
Both 
breast 
and 
bottle fed 
   If formula, name of the milk –  
 
9.  Was boiling water used to make the bottle? Yes No 
 
10.  What other food was use to feed the baby? 
 
 
11.  Does the mother have the clinic card? 
      
Yes No 
     If yes – keep the card for the pathologist.  If no – ask the mother to bring it to the facility   
12.  Was the baby sick before it died? 
 
 
Yes No 
 
      If yes 
 
<24h >24h > 2 weeks Never 
     a)  Did the baby have a cold/ runny nose? 
 
 
    
     b)  was the baby coughing? 
 
    
     c)  did the baby have diarrhea (runny tummy)? 
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     d)  Was the baby unusually restless / irritable? 
 
    
     e)  Was the baby crying more than usual? 
 
    
      f)  Was there a difference /change in the appetite / 
feeding? 
 
    
     g)  Was the baby vomiting? 
 
    
     h)  Any fits / seizures? 
 
    
     i)  did the baby have a fever / showed increased sweating? 
 
    
     j)  Was the baby listless?  (floppy) 
 
    
     k)  did the baby turn blue? 
 
    
13.  Was the now deceased baby taken to  Hospital clinic doctor Pharmacy 
 
 Traditional 
healer 
Other   
14.  Did the baby come in contact with someone who is sick in the past two weeks? Yes No 
 
     If yes – who? 
 
 
15.  Did the baby ever suddenly stopped breathing? Yes No Unknown 
16.  When was the baby’s last vaccination? 
 
18.  Is the baby known to be allergic to anything? Yes No Unknown 
 
       If yes, what? 
 
19.  Did the family visit another country prior to the death of the baby? Yes No 
 
       If yes, give details 
 
 
20.  Was the baby admitted to hospital in the past week before the death? Yes No 
 
      a) If yes, for how long and where: 
 
 
      b) Why? 
 
 
     c) Discharge date? 
 
     d) Condition of baby after discharge: 
 
 
     e)  Medication after discharge from the hospital (names please) 
 
21.  Was the baby taken to a traditional healer? 
 
Yes 
 
No 
 
      a)If yes, date when the baby was taken to the healer: 
 
  FPS006(b) 
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     b) What was given? 
 
 
    c) Ask for the medication to be given to the pathologist. 
 
    d)  Condition of the baby after going to the healer? 
 
 
21.  What did the baby wear when it died?  (list clothing) 
 
 
 
 
 
 
 
Section F 
About the mother 
 
1.  Is the mother Married Single 
 
2.  Is the mother employed? Yes No 
 
3.  Age of the mother? 
 
4.  What standard of schooling did she achieve? 
 
5.  Was she on contraception before she fell pregnant? 
 
Yes No 
6.  Did she take iron and vitamin tablets during her pregnancy? 
 
Yes No 
7.  Did she receive antenatal care? 
 
Yes No 
8.  Did the mother have diabetes in pregnancy? 
 
Yes No 
9.  Did the mother have high blood pressure in pregnancy? 
 
Yes No 
10.  Did the mother gain weight adequately in pregnancy? 
 
Yes No 
11.  Was she diagnosed with any illness during the pregnancy eg. HIV? 
 
Yes No 
12.  Was the mother on any medication during the pregnancy? 
 
Yes No 
     If yes, what medication:   
 
 
13.  Were there any difficulties during the delivery? 
 
Yes No 
     If yes, what? 
 
 
14.  Were there any problems with the baby after the delivery? 
 
Yes No 
   If yes, what? 
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15.  Was any specific instruction given about specific health care for the baby? 
 
Yes No 
If yes, what? 
 
 
 
16.  Was she depressed after the pregnancy? 
 
Yes No 
17.  Did she get any treatment? 
 
Yes No 
18.  How many babyren does she have? 
 
19.  How old are they? 
 
20.  Are they healthy? 
 
Yes No 
21.  Do any of the babyren have learning disability? 
 
Yes No 
22.  Do the living babyren have the same father as the deceased baby? 
 
Yes No 
23.  Does she look after the baby? 
 
Yes No 
24.  If not, who looks after the baby? 
 
25.  Why is the mother unable to look after the baby? 
 
 
26.  Did the mother smoke during the pregnancy? 
 
Yes No 
       If yes, how many per day? 
 
27.  Did the mother drink during the pregnancy? 
 
Yes No 
        a)  What did she drink? 
 
Beer 
 
Wine 
 
Spirits Other 
 
 
       b)  how much did she drink? 
 
Every day 
 
Now and 
again 
Weekends 
1 glass 
 
Every day 
 
Now and 
again 
Weekends 
> 1 glass 
 
Every day 
 
Now and 
again 
Weekends 
A bottle of alcohol 
 
Every day 
 
Now and 
again 
Weekends 
>  1 bottle 
 
Every day 
 
Now and 
again 
Weekends 
28.  Does she use drugs? 
 
Yes No 
    a)  If yes, what drugs does she use? 
 
Tik 
 
Cocaine 
 
Heroin 
 
Mandrax Other 
    b) How often does she use drugs? Every day 
 
Now and 
again 
Weekends 
29.  Does the mother smoke after the pregnancy?  
 
Yes No 
30.  Does the mother know that smoking harms the unborn baby? 
 
Yes No 
31.  Does the husband/partner drinks? 
 
Yes No 
  FPS006(b) 
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32.  Does the mother drink after the pregnancy? 
 
Yes No 
33.  Do the parents of the mother drink? 
 
Yes No 
34.  Does the mother know that alcohol harms the unborn baby? 
 
Yes No 
35.  Did the mother have a previous baby that died suddenly? 
 
Yes No 
       a)  If yes, how many died? 
 
       b)  At what age? 
 
      c)  Was a PM done?   
 
Yes No 
           If yes, where was it done? 
 
36.  Did the mother have a previous stillbirth? 
 
Yes No 
   
Section G 
Household environment 
 
1.  Place where the baby lives House Shack Other 
 
 
2.  Number of bedrooms? 
 
 
3.  Is the room in which the baby was found well ventilated? 
 
Yes No 
4.  Odour(s) present in the room the baby slept in? 
 
Yes No 
5.  Peeling paint in the room the baby slept in? 
 
Yes No 
6.  Fungal growth (mould) in the room the baby slept in? 
 
Yes No 
7.  Are there pets in the house? 
 
Yes No 
    If yes, type and number: 
 
 
8.  Was the following in the room where the baby slept to heat 
the room? 
 
Electric 
heater 
 
“Galley” 
 
Fire Other 
     Describe other –  
 
9.  Number of adults in the dwelling? 
 
 
10.  Number of babyren in the dwelling? 
 
 
11.  Total number of people in the dwelling? 
 
 
12.  Estimated monthly income? 
 
 
13.  Number of smokers in the dwelling? 
 
 
 
14.  Are there mentally retarded/ challenged people in the dwelling? 
 
Yes No 
  FPS006(b) 
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COMMENTS TO PATHOLOGIST FROM THE FORENSIC OFFICER WHO ATTENDED THE SCENE AND INTERVIEWED DURING ID 
PROCESS: 
 
 
 
 
 
 
 
 
 
ITEMS RETAINED AT THE SCENE OR FROM THE MOTHER DURING INTERVIEW 
 
 
 
Date: 
          
Signature / Thumbprint of deponent 
 
I certify that the above statement was taken down by myself and that the deponent has 
acknowledged that he / she knows and understands the contents hereof.  
 
 Date _________________________________   Time:  ________________________________   
  
Place: ________________________________ 
                                                                           
_____________________________ 
 
Department of Health 
Forensic Pathology Laboratory 
 
FPS 006(a) 
FORENSIC PATHOLOGY SERVICE 
 
SUD [Complete If a person older than one year of age Should Suddenly And Unexpectedly 
Die] 
FPS laboratory________________________________                     WC _______________________ 
Full Name of deceased ________________________________    Scene Address  
 
 
 
Section A. 
Who gives the history/ information in this case e.g. 
husband/wife/partner/son/daughter/mother/father/brother/sister/other relative(give details) 
Name:                                                                                              Relationship: 
 
Address:                                                                                           Contact telephone number: 
 
 
ID Number: 
 
Home Address of Deceased:        
 
                                                                            
Age of Deceased  
    
Date of birth:   
Race:  
  
Sex: 
 
Section B 
Person(s) at/called to the scene and relationship 
Name/relationship Date Time 
 
Name/relationship Date Time 
 
Name/relationship Date Time 
 
Police response/name Date Time 
 
Paramedic response/name 
 
Date Time 
 
If the deceased was taken to hospital 
 
Yes No 
Name of hospital 
 
Part 1:  Scene Questionnaire and Observations 
Date:                     Time:                  Name of Forensic officer:  
WC____________________      FPS006(a) 
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Date of arrival: 
 
Time of arrival: 
 
Name of attending doctor  Contact Number: 
When was the death certified and by whom Date Time 
Was resuscitation done? 
 
Who by; 
 
Where: 
 
Comment:  Get copies of doctors notes 
Section C 
Household environment: 
Place where deceased lived at time of death: Formal Informal Other 
Did the deceased live alone? Yes No 
Did anyone witness the death? Yes No 
Number of bedrooms in dwelling: 
Is the room in which the deceased adult is found well ventilated?   Yes No 
Was the room locked from the inside?   Yes No 
Odour(s) present in the room the deceased adult slept in?  Yes No 
Peeling paint in the room the deceased adult slept in? Yes No 
Medication present on the scene; if so record. Yes No 
Alcohol present on the scene? Yes No 
Was the medication retained by FPS? Yes No 
Illegal substances present on the scene; if so describe. Yes No 
 
 
 
Did the deceased call a friend/someone prior to death? Yes No 
Are there pets in the house?   
If yes – type and number?     
Yes No 
  
Was there a heater or open fire/gas heater/ galley blik or other  heating device in room where 
deceased adult slept? 
Yes No 
WC____________________      FPS006(a) 
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In what position was the deceased found lying?  
Has the body of the deceased been moved? Yes No 
Were there any covers/ clothing etc over the deceased adult’s head? Yes No 
Was the deceased adult squashed/wedged between anything /(object- 
was the person lying under any heavy material eg bricks/rubble? If so, describe. 
Yes 
 
No 
Comments from forensic officer who attended the scene: 
 
SECTION D – Did the deceased suffer from any of the following symptoms prior to death? 
Swelling of ankles 
Weight loss 
Fever 
Coughing up blood 
Fits 
Breathlessness 
Foaming at the mouth 
Chest pain 
Other symptoms prior to death- If yes, please describe 
 
 
 
 
 
 
Section E 
Circumstances of death / details about events before death 
 
1.  When was the deceased  last seen alive? 
 
Date Time 
2.  Who last saw the deceasedalive? 
 
 
3.  When was the deceased found dead? 
 
Date Time 
4.  Who found the deceased’s body on the scene? 
 
 
Part 2:  Facility Questionnaire 
Date:                     Time:                  Name of FPS Official:  
Yes            No  
Yes            No  
Yes            No  
Yes            No  
Yes            No  
Yes            No  
Yes     No 
Yes     No 
Yes            No  
WC____________________      FPS006(a) 
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Relationship of finder 
 
 
Age of finder 
 
 
 
5.  Did anyone witness the death? Yes No 
 
If yes, what did the deceased do prior to death? Was he/she 
Fitting Yes No 
Holding head in pain 
 
Yes 
 
No 
 
Breathlessness 
 
Yes 
 
No 
 
Foaming at the mouth 
 
Yes 
 
No 
 
Grabbing of chest 
 
Yes 
 
No 
 
Other-  Describe 
 
 
 
6.  Did the deceased sustain any injuries at the time of death?   
                                 
Yes 
 
No 
 
 If YES: Describe how it happened 
 
7. Was the deceased ill prior to death?                                                                                                                
Yes No 
 
 
a) If yes – What was wrong? 
 
b) For how long was the illness present as described above?   (PLEASE CIRCLE AND ELABORATE)                            
<24hrs                  1day-2weeks        >2weeks 
 
 
 
 
 
 
 
 
 
8.  a) Did the deceased suffer from a chronic illness/infection? If so; what? 
Diabetes Yes 
 
No 
Epilepsy 
 
Yes 
 
No 
 
Asthma 
 
Yes 
 
No 
 
Cancer and site of cancer 
 
Yes 
 
No 
 
WC____________________      FPS006(a) 
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High blood pressure 
 
Yes 
 
No 
 
Heart problems 
 
Yes 
 
No 
 
Kidney problems 
 
Yes 
 
No 
 
HIV 
 
Yes 
 
No 
 
TB    
 
Yes 
 
No 
 
Allergies 
 
Yes 
 
No 
 
Other Yes No 
   
Mental disease 
 
Yes 
 
No 
 
Malaria Yes No 
 
b)   Was the deceased adult taken/go to a doctor or pharmacy or clinic or traditional 
healer for the illness? 
Yes No 
When (date and time) Date Time 
Did the deceased use the medication as prescribed? 
 
Yes 
 
No 
 
Contact details of the attending doctor: 
 
 
 
9.  Was the deceased recently adult admitted to a hospital or clinic for the illness? 
 
Yes 
 
No 
 
When (date and time)? Yes 
 
No 
 
Contact details of the attending doctor 
 
 
Retain hospital records if the admission was recent 
 
Yes 
 
No 
 
10.  Was the deceased on any medication including chronic medication? Yes No 
If yes, What medication  (names please of medication) 
 
 
 
 
 
11.  Did the deceased vomit? 
(If the answer is NO please proceed to question 15) 
Yes 
 
No 
 
Don’t 
know 
12.  For how long did the deceased vomit? Days Weeks Months 
 
13.  Did the vomit look like a coffee coloured fluid or bright red like blood or some other? Coffee Blood Other 
Describe 
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14.  When the vomiting was most severe, how many times, did the deceased vomit per 
day? 
 
15.  Did the deceased have abdominal pain? 
(If the answer is NO please proceed to question 21) 
Yes 
 
No 
 
Don’t 
know 
 
16.  For how long did the deceased have abdominal pain? Days Weeks Months 
 
17.  Did the deceased have abdominal distension/swelling? Yes No Don’t 
Know 
 
18.  For how long did the deceased have abdominal distension/swelling? Days  Weeks Months 
 
19.  Was there a period of a day or longer during which the deceased could not pass 
stool? 
Yes No Don’t  
know 
 
20.  Did the deceased have difficulty or pain when swallowing? Yes  No Don’t 
know 
 
21.  Did the deceased have a headache? 
(If the answer is NO please proceed to question 25) 
Yes 
 
No 
 
Don’t 
know 
 
22.  For how long did the deceased have a headache? Days Months Years 
 
23.  Was the headache severe? Yes No Don’t 
know 
 
24.  Did the headache improve upon lying down? Yes No Don’t  
know 
 
25.  Did the deceased have a stiff or painful neck? 
(If the answer is NO please proceed to question 29) 
Yes 
 
No 
 
Don’t 
know  
 
26.  Did the deceased have mental confusion? Yes No Don’t 
know 
 
27.  For how long did the deceased have mental confusion? Days 
 
Months Years 
28.  Did the mental confusion start suddenly within a single day or slowly over many 
days? 
Single day Many days 
 
29.  Did the deceased become unconscious? 
(If the answer is NO please proceed to question 32) 
Yes 
 
No 
 
Don’t 
know 
 
30.  For how long was the deceased unconscious? Min Hours Days 
 
31.  Did the unconsciousness start suddenly within a single day or slowly over many 
days? 
Single day Many days 
 
32.  Did the deceased have convulsions/fits? 
(If the answer is NO please proceed to question 36) 
Yes 
 
No 
 
Don’t 
know 
 
33.  For how long did the deceased have convulsions? Days Months Years 
 
34.  How many times did the deceased have convulsions during the 72hours prior to 
death? 
 
35.  Did the deceased have stiffness of the whole body? Yes No Don’t 
know 
 
36.  Did the deceased have weakness or paralysis of the body? Yes No Don’t  
WC____________________      FPS006(a) 
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(If the answer is NO please proceed to question 43)   know 
 
37.  Did the deceased have weakness or paralysis of one side of the body? Yes  No Don’t 
know 
 
38.  For how long did the deceased have paralysis of one side of the body? Days Months Years 
39.  Did the paralysis of one side of the body start suddenly within a single day or slowly  
over many days? 
Single day 
 
Many days 
 
40.  Did the deceased have paralysis of the lower limbs? Yes No Don’t 
know 
 
41.  For how long did the deceased have paralysis of the lower limbs? Days Months Years 
42.  Did the paralysis of the lower limbs start suddenly within a single day or slowly over 
many days? 
Single day Many days 
43.  Did the deceased receive any treatment for the illness that led to death? Yes No Don’t  
know 
 
SURGICAL HISTORY 
 
Did the deceased have an operation/s?  
 
Yes 
 
 
 
No 
 
 
 
Don’t 
know 
If yes, when?  
 
Date: 
 
Name of Hospital/Clinic 
 
 
 
 
Nature of operation-Describe 
 
 
 
 
TRAVEL HISTORY 
 
Did the deceased travel outside the Province / Country? 
 
Yes 
 
 
 
No 
 
Don’t 
know 
 
If yes, where and when? 
 
 
 
 
 
 
FAMILY HISTORY OF ANY ILLNESS 
  
Heart disease 
 
Yes 
 
 
 
No 
 
Which family member had heart disease 
 
 
 
Asthma                                                                                  Yes 
 
No 
 
Cancer                                                                                 
 
Yes 
 
No 
 
Sudden death                                                                           
                   
Yes 
 
No 
 
At what age did they pass away 
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TRAUMA HISTORY 
Was the deceased injured in an assault or in any accident? 
Yes  
 
No  
 
Don’t 
know 
 
If yes, when did it occur?  
What specifically was injured?  
Did the person need admission to hospital after the injury? Yes 
 
No 
 
Don’t 
know 
 
How was the person after the incident?     
Well 
 
OK 
 
Unwell 
 
 
If unwell, describe 
 
 
 
 
For how long did the illness last? Days Weeks Months 
SOCIAL HISTORY 
Did the deceased regularly use alcohol?                            
 
Yes No  Don’t  
Know 
If yes, what?  Beer Wine Brandy Papsak Other 
 
If yes, how much? 
 
     
Did the deceased use alcohol on the day/night of death? Yes No 
 
Don’t 
Know 
 
Did the deceased regularly use drugs?                                                                         Yes 
 
No 
 
Don’t 
know 
 
If yes, what drugs were used? TIK Mandrax Dagga Other 
 
Describe Other:   
 
 
 
is she pregnant  Yes 
 
No 
 
Don’t 
know 
 If YES ask about antenatal clinic attendance 
 
What clinic 
 
If the deceased is female, was she on contraception                                      Name, if yes Yes 
 
 
No 
 
Don’t  
know 
If YES name of contraceptive:  
 
 
 
f)  Did the deceased smoke? 
If so what:  cigarettes /pipe / other?                                                                            
 
Yes No 
 
Don’t  
know 
How often/ many per day?         
 
EMPLOYMENT HISTORY 
Was the person employed 
 
 
Yes 
 
No 
If yes, what did he/she do?  
  
Was the person exposed to any hazardous substances prior to death, if so, what. 
 
WC____________________      FPS006(a) 
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Did the person ever work in a mine? Yes No Don’t 
know 
History of an animal/insect/snake bite 
If yes what creature? 
Yes 
 
No 
 
Don’t 
know 
 
History of Bee sting Yes No Don’t 
know 
 
COMMENTS TO PATHOLOGIST FROM THE FORENSIC PATHOLOGY OFFICER WHO INTERVIEWED: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEMS RETAINED AT THE SCENE OR DURING INTERVIEW 
 
 
 
 
 
 
 
 
Date: 
 
 
 
 
Signature / Thumbprint of deponent 
 
I certify that the above statement was taken down by myself and that the deponent has acknowledged that he / 
she knows and understands the contents hereof.  
 
 Date _________________________________  Time:  ________________________  Place: ________________________________ 
                                                                           
_____________________________ 
 
Name of Forensic Pathology Official: _______________________________ 
Department of Health, Forensic Pathology Laboratory 
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